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Inflammatory bowel disease (IBD) has posed serious threats to the human health, 
which lead to chronic malabsorption of nutrients, abnormal pain and rectal bleeding. Both 
genetic predisposition and environmental factors contribute to the onset of IBD.      
Multiple studies suggested that dysbiosis in colon plays an important role in the 
development of colitis, and gut microbiota composition are different between patients 
with IBD and healthy individuals. Intake of whole foods, such as fruits and vegetables, 
may confer health benefits to the host. The beneficial effects of fruits and vegetables 
mainly attribute to their richness of polyphenols and microbiota-accessible carbohydrates 
(MACs). Components in fruits and vegetables modulate composition and associated 
vii 
 
functions of the gut microbiota, while gut microbiota can transform components in fruits 
and vegetables to produce metabolites that are bioactive and important for health. 
Accumulating evidence suggests that colonic inflammation may be prevented by 
increased consumption of certain fruits and vegetables such as berries. Cranberry and 
strawberry are abundant of polyphenols with various health benefits. Most studies 
focused on extractable polyphenols (EP), non-extractable polyphenols (NEP) were often 
neglected, although NEP may possess important biological functions. NEP is not 
significantly released from the food matrix during digestion in the stomach or small 
intestine, therefor they reach colon nearly intact. In the colon, the potential interaction 
between gut microbiota and NEP could also play an important role in colon health. NEP 
could be biotransformed by gut microbiota to produce bioactive metabolites that may 
contribute to the promotion of colon health as well. Therefore, it is important to 
investigate the interaction of gut microbiota and NEP in the colon in terms of production 
of bioactive metabolites. Meanwhile, composition and functions of gut microbiota can be 
altered by the presence of polyphenols in the colon, which in turn could affect colon 
health. The objective of this work was to characterize EP and NEP fractions from whole 
cranberry and strawberry and determine their potential in anti-inflammation and anti-
colon cancer. EP and NEP from cranberry and strawberry showed anti-inflammatory 
effects in inhibiting LPS-induced production of nitric oxide in macrophages, which was 
accompanied by decreased expression of iNOS and increased expression of HO-1. EP 
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and NEP from cranberry and strawberry showed anti-cancer capacities in HCT116 cells. 
Flow cytometry analysis demonstrated that NEP caused a cell cycle arrest and induced a 
significant cellular apoptosis in colon cancer cells. 
Furthermore, this study determined the protective effects of whole strawberry 
(WS) against dextran sulfate sodium (DSS)-induced colitis in mice. In colitic mice, 
dietary WS reduced the disease activity index (DAI), prevented the colon shortening and 
spleen enlargement, and alleviated the colonic tissue damages. The abundance of pro-
inflammatory immune cells was reduced by dietary WS in the colonic mucosa, which 
was accompanied by the suppression of overproduction of pro-inflammatory cytokines. 
Western blotting and immunohistochemical analysis revealed that dietary WS decreased 
the expression of pro-inflammatory proteins in the colonic mucosa. Moreover, dietary 
WS partially reversed the alteration of gut microbiota in the colitic mice by increasing the 
abundance of potential beneficial bacteria, e.g. Bifidobacterium and Lactobacillus, and 
decreasing the abundance of potential harmful bacteria, e.g. Dorea and Bilophila. Dietary 
WS also restored the decreased production of short chain fatty acids (SCFAs) in the 
cecum of the colitic mice. The results revealed the anti-inflammatory effects and 
mechanisms of dietary WS in the colon, which is critical for the rational utilization of 
strawberry for the prevention of inflammation-driven diseases.  
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Trillions of microorganisms inhabit in the large intestine. The main phyla are 
Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria, Fusobacteria and 
Verrucomicrobia [1]. In recent years, studies about gut microbiota are blooming. An 
increasing number of diseases, such as obesity, inflammatory bowel disease, 
cardiovascular diseases, and metabolic syndrome, have been associated with abnormality 
in gut microbiota. Gut microbiota could be profoundly influenced by many factors, such 
as diet and health status [2]. Modulation of gut microbiota by diet is a promising and 
effective way to benefit the host. The effects of diet on the composition and function of 
gut microbiota can be beneficial or harmful. In general, dietary intake of whole fruits and 
vegetables has been known to beneficially affect gut microbiota by promoting the growth 
of beneficial bacteria and/or inhibiting the growth of the harmful bacteria (Figure 1). 
Fruits and vegetables are rich in microbiota-accessible carbohydrates (MACs), such as 
oligosaccharides, pectin, cellulose, inulin, lignans, and resistant starches, that serve as 
substrate for certain beneficial bacteria [3, 4]. Microflora ferments MACs to produce 
short-chain fatty acids (SCFAs), which in turn impact bacterial composition. On the other 
hand, polyphenols in fruits and vegetables can be degraded by gut bacteria to various 
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metabolites, and both polyphenols and their metabolites can modulate gut microbiota. 
This review focus on the effects of whole foods, e.g., fruits and vegetables on gut 
microbiota and microbiota-associated disease, e.g., obesity and colonic inflammation. 
Inflammatory bowel disease (IBD) has posed serious threats to the human health 
[5], which lead to chronic malabsorption of nutrients, abnormal pain and rectal bleeding. 
Both genetic predisposition and environmental factors contribute to the onset of IBD [6]. 
Pathological immune response against exotic antigen and bacterial drives the progression 
of IBD [7]. Multiple studies suggested that dysbiosis in colon plays an important role in 
the development of colitis, and gut microbiota composition are different between patients 
with IBD and healthy individuals [8]. The incidence of colonic inflammation has also 
been associated with dietary patterns through the modification of gut microbiota [9]. The 
diet with high fat, high sugar, high protein and low fiber has been proposed to increase 
the risk of IBD. In contrast, dietary consumption of fruits and vegetables has been 
associated with lowered risk of IBD [10]. 
Accumulating evidence suggests that colonic inflammation may be prevented by 
increased consumption of certain fruits and vegetables such as berries [10, 11]. Berries 
(e.g. chokeberry, red raspberry, strawberry, cowberry) and their extracts have been shown 
to have anti-inflammatory and anticancer effects in intestine in various animal models 
such as azoxymethane-induced rat colon cancer model, Apc 1638+/- mouse and Muc2-/- 
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mouse model, and DSS-induced colitis models [12-14]. Polyphenols are a major class of 
dietary phytochemicals which are responsible for many health benefits. Current research 
on dietary polyphenols mainly focus on a fraction of polyphenols, known as extractable 
polyphenols (EP) [15, 16]. EP can be extracted from food with aqueous-organic solvents 
(e.g. water, methanol, ethanol, acetone) [17, 18], and are often considered as “total 
phenolic content” for various biological studies. However, another fraction of 
polyphenols remains in the residues after solvent extraction, and they are known as non-
extractable polyphenols (NEP) [16, 19]. NEP are mainly polyphenols that bound to 
dietary fiber or other macromolecules through hydrophobic interaction, hydrogen 
bonding and covalent bonding [15, 16]. NEP is not significantly released from the food 
matrix during digestion in the stomach or small intestine, therefor they reach colon nearly 
intact [20]. In the colon, NEP may be released from food matrix by the action of 
microbiota and become bioavailable and bioactive. In contrast, EP tend to be absorbed 
and metabolized in the upper gastrointestinal tract, therefore, their biological fate is quite 
different from that of NEP. Only unabsorbed EP and their metabolites could reach the 
colon. The better colonic bioavailability of NEP than EP makes NEP promising 
candidates for promoting colon health.  
Cranberry is a native berry fruit of North America, and it is abundant of polyphenols 
including flavan 3-ols, proanthocyanidins, anthocyanins and phenolic acids [21]. 
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Majority of studies on cranberry have been focused on its antibacterial actions [22]. To 
date, the inhibitory effects of cranberry on colonic inflammation and colon cancer have 
not been adequately studied. Cranberry extracts have been shown to inhibit colon cancer 
cell growth and suppress pro-inflammatory enzymes expression [21]. Strawberry is one 
of the most popular berry fruits, which is abundant in polyphenols that have been 
associated with anti-oxidation, anti-inflammation and anti-cancer bioactivities. 
Strawberry juice exhibited anti-inflammatory effects in lipopolysaccharide-treated 
macrophage by decreasing the production of pro-inflammatory cytokines [23], and 
inhibited the cell proliferation of human colon cancer cell lines [17]. A human study 
showed that consumption of strawberry could increase the serum antioxidant capacity 
[24]. The consumption of strawberry beverage was associated with the amelioration of 
postprandial inflammatory response [25]. These evidences suggested the promising 
bioactivity of berry fruits against the colonic inflammation. Whole strawberry contains 
vitamins, flavonoids, phenolic acids, anthocyanins, polysaccharides and fiber [17], which 
may exhibit stronger anti-inflammatory effects when compared to the extracts. However, 
there is no detailed mechanistic information available on the potential protective effects 







Trillions of microorganisms inhabit in the large intestine. The main phyla are 
Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria, Fusobacteria and 
Verrucomicrobia [1]. In recent years, studies about gut microbiota are blooming. An 
increasing number of diseases, such as obesity, inflammatory bowel disease, 
cardiovascular diseases, and metabolic syndrome, have been associated with abnormality 
in gut microbiota. Gut microbiota could be profoundly influenced by many factors, such 
as diet and health status [2]. Modulation of gut microbiota by diet is a promising and 
effective way to benefit the host. The effects of diet on the composition and function of 
gut microbiota can be beneficial or harmful. In general, dietary intake of whole fruits and 
vegetables has been known to beneficially affect gut microbiota by promoting the growth 
of beneficial bacteria and/or inhibiting the growth of the harmful bacteria (Figure 1). 
Fruits and vegetables are rich in microbiota-accessible carbohydrates (MACs), such as 
oligosaccharides, pectin, cellulose, inulin, lignans, and resistant starches, that serve as 
substrate for certain beneficial bacteria [3, 4]. Microflora ferments MACs to produce 
short-chain fatty acids (SCFAs), which in turn impact bacterial composition. On the other 
hand, polyphenols in fruits and vegetables can be degraded by gut bacteria to various 
metabolites, and both polyphenols and their metabolites can modulate gut microbiota. 
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This review focus on the effects of whole foods, e.g., fruits and vegetables on gut 
microbiota and microbiota-associated disease, e.g., obesity and colonic inflammation. 
 
Figure. 1 The interactions between whole foods and gut microbiota. Whole foods such as 
fruits and vegetables are rich in microbiota-accessible carbohydrates and polyphenols. 
microbiota-accessible carbohydrates, such as oligosaccharides, pectin, cellulose, inulin, 
lignans, and resistant starches, are resistant to digestion in the upper gastrointestinal tract 
prior to reaching the large intestine where they interact with gut microbiota. This 
interaction may lead to (i) altered gut microbiota, and (ii) the production of short-chain 
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fatty acids from fermentation of microbiota-accessible carbohydrates by microbiota, and 
short-chain fatty acids may also modulate microbiota composition.  After consumption of 
whole fruits and vegetables, a large portion of their polyphenols accumulate in the large 
intestine where they may interact with gut microbiota to (i) modify the structure of 
microbial community, and (ii) produce bioactive metabolites, such as phenolic acids, via 
microbiota-mediated metabolism of polyphenols. The microbial metabolites of 
polyphenols could modulate gut microbiota as well. The overall outcome of interactions 
between whole foods and gut microbiota may be an increased abundance of beneficial 
bacteria and a decreased abundance of harmful bacteria. Moreover, short-chain fatty acids 
and phenolic acids may also interact with host tissues such as colonic epithelia to impact 
host health. 
2.1 Interactions between Whole Foods and Gut Microbiota in Disease-free Populations 
Whole fruits and vegetables are known to be good food choices to maintain and 
promote health. Various fruits and vegetables have been studied to determine their effects 
on gut microbiota in healthy, disease-free populations including both humans and 
animals. This section provided a summary of the modulating effects of fruits and 
vegetables on gut microbiota, as well as the interactions between gut microbiota and the 
major bioactive components of fruits and vegetables. Table 1 summarized representative 
studies on the impacts of whole foods and their components on gut microbiota. 
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model Dose Duration Effects on gut microbiota Reference 
apple 
Fresh apple human 









rats Oral, 10 g/day 4 weeks ↓Bacteroides 
[27]  
Apple pectin  rats Oral, 7% pectin 4 weeks 
↑Anaeroplasma, ↑Anaerostipes, ↑Roseburia, 
↑Clostridium coccoides, ↓Alistipes, 












mice Oral, 10% w/w 7 weeks 
↓Firmicutes, ↑Bacteroidetes, 






rats Oral, 5% w/w 6 weeks 
↑Anaerostipes, ↑Akkermansia, ↑Desulfovibrio, 





rats Oral, 0.2% w/w 6 weeks 





rats Oral, 2.25% w/w 6 weeks 
↑Anaerostipes, ↑Desulfovibrio, 
↑Coprobacillus, ↑Victivallis, ↑Mucispirilum, 





drink (25 g of 
wild 
blueberry 
powder in 250 






















Gavage, 4 ml of 
extracts/kg body 
weight/day 






















human Oral, 8 oz/day 5 days 
high-Bacteroides individuals: ↓Bacteroides, 




↑Clostridium, ↑Clostridium XI, ↑Dialister, 
↑Coprococcus, ↑Lactobacillu, ↑Streptococcus. 
low-Bacteroides individuals: 
↓Lachnospiraceae, ↓Streptococcus, ↓Dialister, 
↓Blautia, ↓Roseburia, ↑Bacteroides, 
↑Prevotella, ↑Alistipes, ↑Clsotridium IV and 




citrus pectin mice Oral, 15% w/w 4 weeks ↑Bacteroidetes, ↓Firmicutes [37] 

























5 days ↓Firmicutes, ↑Bacteroidetes [40] 
cranberry juice human 
Oral, 
200mL/day/person 






pigs Oral, 25% w/w 14 days 
↑Bacteroides, ↓Enterobacteria, ↓Escherichia 
coli [42]  










rats Oral, 10% w/w 4 weeks ↑Lachnospiraceae 




 (without peel) 
rats Oral, 10% w/w 4 weeks 
↑Bacteroides–Prevotella–Porphyromonas 







20 mL ddH2O) 
mice 
Gavage, 0.52, 
1.04, 2.07 g/kg 
bw/day 
7 weeks 










↑Actinobacteria, ↑Butyrivibrio, ↑Enterobacter, 
↑Escherichia, ↑Lactobacillus, ↑Prevotella, 

























rats Oral, 10% w/w 4 days  









Oral, 0.1, 0.3, and 
0.9% w/w 
30 days 
































soybean flour rats Oral, 41.5% w/w 14 days ↑Prevotella, ↑Eubacterium 
[53] 






2.1.1 Whole Fruits and Vegetables Beneficially Impact Gut Microbiota 
Among the major phyla of gut microbiota, Firmicutes and Bacteroidetes represent 
more than 90% of the phylogenetic types [1, 54]. Intake of whole fruits and vegetables 
could modulate the growth of Firmicutes and Bacteroidetes. A lowered ratio of 
Firmicutes to Bacteroidetes (F/B) is considered as a marker of healthier gut microbiota 
[28]. Daily consumption of 200 g of cooked broccoli for 18 days in human volunteers 
reduced the relative fecal abundance of Firmicutes and increase that of Bacteroidetes. 
These effects were ascribed to fiber and glucosinolates found in broccoli [47]. Human 
intake of cranberry (30 grams of freeze-dried powder per day for 5 days) also led to a 
decrease in the fecal abundance of Firmicutes and an increase in Bacteroidetes. 
Consistent with these human studies, dietary treatment with freeze-dried black raspberry 
powder (10% w/w in diet) to mice for 6 weeks lowered the F/B ratio in the fecal 
microbiota [28]. Feeding of cooked navy bean or black bean to mice altered fecal 
microbiota structure showing an increasing trend in the abundance of Bacteroidetes. The 
fecal abundance of S24-7, a major family of Bacteroidetes, was significantly increased, 
and the fecal abundance of Oscillospira, Ruminococcus gnavus, Lactococcus, 
Coprococcus and Streptococcus, all members from Firmicutes, were remarkably 
decreased by the intake of the beans. Moreover, concomitant with the altered fecal 
microbiota, dietary bean treatments enhanced multiple aspects of mucus and epithelial 
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barrier integrity in the mouse colon [55].  
Intake of whole fruits and vegetables can promote the growth of certain beneficial 
bacteria, such as Bifidobacterium and Lactobacillus. In human studies, oral intake of 
freeze-dried wild blueberry powder  increased fecal abundance of Bifidobacterium and 
Lactobacillus [31, 56]. After simulated digestion, fermentation of whole apples (Renetta 
and Golden Delicious) with fecal bacteria from healthy donors promoted the growth of 
Bifidobacterium [57]. Whole foods also modulate gut microbiota through inhibiting 
potential harmful microorganisms. Cranberry intake (freeze-dried whole cranberry 
powder, 30 g/day for 5 days) in humans decrease the fecal abundance of bacteria that 
were associated with infection and antibiotic resistance, such as Clostridia and 
Oribacterium [40, 58]. Consumption of 2 apples per day for 2 weeks in human volunteers 
decreased the fecal abundance of lecithinase-positive clostridia, including C. perfringens, 
a potential pathogen for food poisoning  [26]. Whole foods intake also showed inhibitory 
effects on potential harmful bacteria in animal models. Lingonberries in diet (20% w/w) 
caused a decrease in fecal abundance of Lachnospiraceae, Ruminococcus and 
Oscillospira in mice. These microorganisms were linked to obesity and type II diabetes 
[59]. Oral administration of bitter melon (freeze-dried powder without seeds) to rats 
decreased the proportion of the potential endotoxin-producing opportunistic pathogens, 
such as Escherichia, in the fecal microbiota [60]. Dietary treatment with green kiwifruit 
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(freeze-fried powder) decreased the fecal abundance of Escherichia coli [42], and feeding 
white mushroom (Freeze-dried powder) to mice decreased fecal abundance of Clostridia 
[50]. 
It is well recognized that there are considerable inter-individual variations in gut 
microbiota among humans. The difference in the gut microbiota composition may also 
render the individuals difference in responding to the same dietary intervention. For 
example, intake of tart cherry juice induced distinct and inverse responses in gut 
microbiota among human participants who had different initial levels of Bacteroides prior 
to the dietary intervention [36]. After tart cherry juice consumption, low-Bacteroides 
participants showed a decrease in Lachnospiraceae, Ruminococcus and Collinsella, and 
an increase in Bacteroides and Bifidobacterium, whereas, high-Bacteroides participants 
showed opposite changes in fecal microbiota compared to that in low-Bacteroides 
participants, i.e., an increase in Lachnospiraceae, Ruminococcus and Collinsella, and a 
decrease in Bacteroides and Bifidobacterium [36]. The mechanism underlying the 
interesting phenomena warrants further investigation. 
The beneficial alterations of gut microbiota induced by whole fruits and 
vegetables were mainly attributed to microbiota-accessible carbohydrates (MACs) and 
polyphenols found in these whole foods [4]. The interactions between gut microbiota, 
MACs, and polyphenols were discussed below. 
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2.1.2 Interaction between Microbiota-Accessible Carbohydrates (MACs) and Gut 
Microbiota 
MACs are indigestible by host-secreted intestinal enzymes and therefore, reach 
the colon largely intact, where they serve as substrates for certain gut bacteria [3]. Fruits 
and vegetables are generally abundant in multiple types of MACs, such as 
oligosaccharides, pectin, cellulose, inulin, lignans, and resistant starches [61]. Gut 
microbiota is dominated by phyla of Firmicutes and Bacteroidetes, both of which contain 
bacteria that can utilize MACs [62]. MACs interact with bacteria in the colon, resulting in 
favoring or inhibiting the growth of specific bacteria. For example, availability of MACs 
promotes the growth of certain beneficial bacteria that can readily utilize these MACs as 
energy sources, whereas the bacterium-derived metabolites of MACs, such as SCFAs, 
can inhibit the growth of certain harmful bacteria. Consequently, composition of gut 
microbiota can be shaped by availability or unavailability of MACs in the colon. For 
example, Low intake of MACs resulted in a remarkable decrease of taxa and diversity of 
gut bacteria relative to high intake of MACs in humanized mice [4]. High intake of 
MACs was associated with increased fecal richness of Bacteroidetes, especially the 
Prevotella, and depletion of Firmicutes in healthy children. Moreover, children who 
consumed high levels of MACs had higher levels of fecal SCFAs, which was associated 
with the lower abundance of  fecal pathogens, such as Escherichia and Shigella [63]. 
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Apples are abundant in pectin, a soluble fiber [64]. Consumption of 2 apples per day in 
human subjects increased fecal abundance of beneficial bacteria Bifidobacterium and 
Lactobacilli, elevated production of SCFAs, and decreased abundance of potential 
harmful bacteria Enterobacteriaceae and Pseudomonas [26]. In vitro fermentation of 
apple pectin with human fecal bacteria facilitated the growth of Bifidobacterium and 
Lactobacillus, suggesting that pectin in apples was, at least in part, responsible for the 
improved gut microbial ecosystem observed in the apple-eating human subjects [26]. 
Moreover, consumption of citrus pectin (15% w/w in the mouse diet) also led to 
increased fecal abundance of Bacteroidetes and decreased abundance of Firmicutes [37]. 
Cranberry is rich in fibers. A randomized crossover controlled trial demonstrated that 
daily intake of 30 grams of freeze-dried whole cranberry powder (equivalent to 2.3 cups 
of fresh cranberry) in humans led to a lowered F/B ratio in fecal microbiota [40]. These 
effects might be partially due to the action of cranberry fiber because that cranberry-
derived soluble fiber xyloglucans could support the growth of Bifidobacterium longum, a 
beneficial bacterium [65]. Studies in rodents also supported the role of MACs in 
modulating gut microbiota. Six weeks of dietary treatment of fiber-rich white-button 
mushrooms increased the abundance of Ruminococcaceae and Lachnospiraceae families 
in mouse fecal microbiota [51]. Bacteria from these two families were known to  be able 
to utilize plant fibers to produce SCFAs [66, 67]. Additionally, oral administration of 
broccoli and potato fiber significantly increased the fecal abundance of Bacteroides, 
18 
 
Prevotella and Porphyromonas in rats, and importantly, intake of broccoli fiber decreased 
the abundance of the potential pathogens, such as Clostridium perfringens, Escherichia 
coli and Enterococcus spp. [68]. Fiber-rich diet can inhibit the growth of pathogens, 
through the change of pH environment induced by the production of SCFAs [63, 69]. 
Increased microbial diversity is a marker of healthier gut microbiota [28]. Hardy banana 
(Musa basjoo) is rich in resistant starch [70]. Consumption of dried hardy banana powder 
(rich in resistant starch) in diet for 3 weeks led to higher α-diversity and β-diversity, as 
well as a decreased ratio of Firmicutes to Bacteroidetes of fecal microbiota in mice [44]. 
These effects could be ascribed to resistant starch in hardy banana. In support of this 
notion, a 17-week double-blind crossover human study demonstrated that daily intake of 
33 g resistant starch (resistant starch types 4) for three weeks increased the fecal 
abundance of Bacteroidetes and lowered the fecal abundance of  Firmicutes [71]. 
One of the major functions of gut microbiota is to ferment MACs to produce 
SCFAs primarily including acetate, propionate and butyrate. Members from 
Bacteroidetes and Firmicutes produce various enzymes capable of breaking down MACs 
to yield SCFAs, and SCFAs could positively influence gut microbiota and host gut health. 
The higher fecal levels of SCFAs in children consuming high amount of MACs were 
associated with lower abundance of pathogens [63]. In line with this study, a randomized, 
double-blind, placebo-controlled, parallel-group human trial showed that enema with 
19 
 
sodium butyrate during shigellosis led to improvement of rectal histopathology and early 
reduction of inflammation [72]. Furthermore, oral administration of sodium butyrate (200 
mg/kg body weight ) to mice remarkably increased the fecal abundance of potential 
beneficial bacteria, such as Christensenellaceae, Blautia and Lactobacillus [73]. SCFAs 
play important roles in the gut health. The production of SCFAs is a means of recovering 
energy for host body, for example, acetate can be absorbed by the liver and server as 
substrate for the cholesterol synthesis [74]. Importantly, SCFAs possess biological 
activities beneficial to the host. Dietary supplementation of SCFAs in obese rodents or 
humans was shown to result in promising beneficial effects. Administration of butyrate 
(5% w/w) to mice inhibited high-fat diet-induced body weight gain and insulin resistance, 
and butyrate treatment also promoted energy expenditure [75]. Oral intake of inulin-
propionate ester, a means of delivery of propionate to the colon, for 24 weeks in humans 
prevented the weight gain in overweight humans [76]. 
2.1.3 Interactions between Polyphenols and Gut Microbiota 
Polyphenols are abundant in whole fruits and vegetables, and they play important 
roles in improving the gut microbial community. Polyphenols (such as catechins) can be 
absorbed in the small intestine, and a significant portion of them are metabolized and 
excreted back to the intestinal lumen via efflux pump in the intestinal epithelium and bile 
secretion from liver. Conjugated and polymeric polyphenols (such as anthocyanins and 
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proanthocyanidins) have low absorption in the upper gastrointestinal tract and a large 
portion of them accumulate in the colon. In general, abundant amount of dietary 
polyphenols reach the colon intact or in the forms of their metabolites [77]. Polyphenols 
and their metabolites interact with microbiota in the colon in a reciprocal manner as 
bacteria can metabolize these compounds, and these compounds can modulate microbiota 
composition and functions. This reciprocal interaction has been linked to improved host 
health. 
2.1.3.1 The Impact of Gut Microbiota on Polyphenols.  
The biotransformation of polyphenols by gut microbiota in the colon has been 
extensively studied in recent years. Various metabolites have been identified, and they may 
have different biological functions in comparison to their parent polyphenol compounds. 
This is the reason why biotransformation of polyphenols by gut microbiota could play an 
important role in mediating health effects of dietary polyphenols.  For example, flavonoid 
glycosides can be transformed to aglycon that are generally more bioavailable and more 
bioactive. Fission reactions mediated by gut bacteria lead to the breakdown of the ring 
structures of polyphenols and production of various phenolic acids that convey bioactivities 
not offered by the intact polyphenols. 
Although the chemical natures of polyphenols are diverse and complex, they can 
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be broken down by gut microbiota to form much simpler structures such as derivatives of 
phenylacetic, phenylpropionic, phenylbutiric, valeric acids and urolithins [78-80]. 
Feeding freeze-dried powders of cranberry, blueberry or black raspberry to rats resulted 
in urinary excretion of about 20 different phenolic acids with hippuric, 4-
hydroxyphenylacetic and 4-hydroxy-3-methoxyphenylacetic, and  4-
hydroxyphenylpropioic acids being major ones [81]. The production of these phenolic 
acids was ascribed to the microbial breakdown of polyphenols in those berries, and the 
relative urinary abundance of different phenolic acids was dependent on berry types. The 
production of potential microbial metabolites of berry polyphenols was also investigated 
in humans, and the results showed similarity as well as difference between rodents and 
humans in response to dietary consumption of whole berries. Oral intake of wild 
blueberry powder (22 grams per day) in humans for 30 days significantly increased 
plasma levels of benzoic, 2,5-dihydroxybenzoic, vanillic, hippuric, and 3-hydroxyhipuric 
acids, while no significant change was observed in the urinary levels of these metabolites 
[46, 82]. In contrast, the urinary level of hippuric acid was increased about 6-fold while 
those of 2,5-dihydroxybenzoic and vanillic acids did not change after oral intake of 
blueberry powder in rats [81]. In another human study, consumption of cranberry powder 
(30 grams per day) for 5 days increased urinary levels of 3,4-dihydroxyphenylacetic and 
4-hydroxy-3-methoxyphenylacetic acids [40], whereas, cranberry-fed rats showed 
increased urinary level of 4-hydroxy-3-methoxyphenylacetic acid, but not that of 3,4-
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dihydroxyphenylacetic acid [81]. The difference in microbial metabolites of berry 
polyphenols between rodents and humans may be attributed to their differences in gut 
microbiota composition and host metabolism of polyphenols. Besides phenolic acids, 
many other types of microbiota-derived polyphenol metabolites have been or yet to be 
identified. Their contributions to human health is an important topic, which warrants 
further investigation. 
To better understand the mechanism of microbiota-mediated biotransformation of 
polyphenols, it is important to identify the strains of bacteria and their genes/enzymes 
responsible for the production of specific metabolites of polyphenols. For example, 
colonic bacteria could produce multiple enzymes responsible for various deconjugation 
reactions of polyphenols, such as β-glucuronidase [83, 84], β-glucosidase [85], esterases 
[86], hydrogenases [87], dehydroxylase [85, 88] and demethylase [85, 88, 89]. 
Eubacterium ramulus and Clostridium saccbarogumia were able to convert cyanidin 3-
glucoside, a common anthocyanin from berry fruits to 3,4-dihydroxybenzoic acid and 
2,4,6-trihydroxybenzaldehyde [90]. Streptococcus thermophiles and Lactobacillus 
plantarum broke down mulberry anthocyanins to form chlorogenic acid, caffeic acid and 
ferulic acid [91]. Bifidobacterium lactis and Lactobacillus gasseri produced cinnamoyl 
esterase that converted chlorogenic acid to hydroxycinnamate and ferulic acid [92]. 
Although information on specific gut microorganism and their genes responsible for the 
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production of bioactive polyphenol metabolites is accumulating, the overall 
understanding of this subject remains preliminary, which significantly limited our ability 
to elucidate the complex interplay between dietary components and gut microbiota.  
2.1.3.2 Modulation of gut microbiota by polyphenols from whole fruits and vegetables 
As a class of major bioactive components of fruits and vegetables, polyphenols 
could modulate gut microbiota through stimulation of beneficial bacteria and inhibition 
of pathogens. The effects of polyphenol-rich extracts of fruits and vegetables on gut 
microbiota have been studied in humans and animals. The administration of 1% (w/w in 
diet) of grape seed extract in pigs for 6 days altered gut microbiota composition, i.e., 
increased abundance of potential beneficial bacteria, such as Lachnospiraceae, 
Ruminococcaceae, and Lacobacillus [93]. Lachnospiraceae and Ruminococcaceae are 
two families of bacteria in the order Clostridiales that could produce short-chain fatty 
acids by fermenting dietary fiber, thereby potentially promoting intestinal health [94].  
The early-life supplementation of a grape pomace extract (200 mg/Kg·bw by daily 
gavage for 12 days) in mice caused an inhibition of norank_f_Lachnospiraceae, 
unclassified_f_Lachnospiraceae, Mucispirillum as well as promotion of Akkermansia and 
Lactobacillus in the fecal microbiota [95]. Mucispirillum is considered a commensal with 
association to the increase of inflammatory biomarkers and colitis [96]. Some members 
of Lachnospiraceae were linked to diet-induced obesity and positively correlated with 
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diabetes [97, 98]. Oral gavage of a bilberry anthocyanin extract (20 mg/kg bw per day for 
10 weeks) to rats increased the fecal abundance of some bacteria potentially beneficial to 
the host, such as Aspergillus, Lactobacillus, Bacteroides, Clostridiaceae-1, the 
Bacteroidales-S24-7-group and the Lachnospiraceae_NK4A136_group, and at the same 
time reduced the abundance of potential harmful bacteria, such as Verrucomicrobia and 
Euryarchaeota [99]. Furthermore, thirty-nine postmenopausal women consumed 100 mg 
of dietary isoflavones daily for two months to characterize changes in microbial 
communities of the intestinal tract. The supplementation elevated the abundance of 
dominant microorganisms of the Clostridium coccoides-Eubacterium rectale cluster, 
Lactobacillus-Enterococcus group, and Bifidobacterium genus, and these organisms were 
considered beneficial to the human health in various aspects [100]. The lower ratio of 
Firmicutes to Bacteroidetes implicates a non-obese and healthier status. The consumption 
of a grape seed proanthocyanidin extract (500 mg/kg bw, daily gavage for 8 days) could 
increase the cecal abundance of Bacteroidetes and Proteobacteria and decreased the F/B 
ratio in rats [101]. In a human study, twenty healthy participants were supplemented with 
1000 mg of a pomegranate extract daily for four weeks, which delivers pomegranate 
polyphenols in an amount equivalent to about 8 oz of pomegranate juice. It was observed 




The metabolites of polyphenols produced by microorganisms in the large intestine 
could also impact gut microbiota. Yersinia enterocolitica is an enteropathogen to humans 
and mammals and causes gastrointestinal infections after the consumption of 
contaminated foods [102]. Urolithins are gut microbiota-derived metabolites of ellagic 
acid. Urolithin-A and urolithin-B inhibited Quorum Sensing-mediated processes such as 
biofilm formation and swimming motility in Y. enterocolitica, which suggested that 
urolithins may exert antipathogenic affect against Y. enterocolitica in the gut [103]. It is 
important to point out that the aforementioned antipathogenic effects of urolithins were 
observed at the concentrations of urolithins achievable in the intestinal tract through 
regular diet. 
2.2. Whole Foods vs. Isolated Major Components of Whole Foods in Modulating Gut 
Microbiota 
2.3. Whole Foods and Gut Microbiota-associated Diseases 
2.3.1 Obesity 
Gut microbiota is a critical factor in the development of obesity. Lacking of gut 
microbiota in germ-free mice resulted in a resistance to the Western diet-induced obesity 
[108], indicating a pivotal role of gut microbiota in obesity. Microorganisms that inhabit 
in the large intestine can ferment MACs and produce SCFAs that are absorbed and 
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provide energy supply for the host [109]. Higher energy intake than expenditure could 
lead to obesity, and the obesity-associated microbiota were found to have higher capacity 
for energy harvest [54]. As the dominant phyla of gut microbiota, both Firmicutes and 
Bacteroidetes are capable of degrading MACs to produce SCFAs. A higher ratio of 
Firmicute to Bacteroidetes was observed in obese mice and humans [54]. Furthermore, 
production of SCFAs in the colon was found to induce obesity by enhancing lipid 
synthesis [110]. Dietary intake of whole fruits and vegetables was reported to impact 
obesity through the modulation of gut microbiota. Table 2 listed the alteration of gut 
microbiota in obese rodents and humans induced by dietary intervention with various 
whole fruits and vegetables. 
The relative abundance of Firmicutes and Bacteroidetes is considered as an 
important marker in the development of obesity. The increase in Firmicutes and decrease 
in Bacteroidetes were reported in obese mice and humans with high BMIs [54, 111]. In 
genetically obese mice, Bacteroidetes abundance was 50% lower than that in lean mice, 
and the microbiota in obese mice was associated with more effective capacity to release 
calories than that in lean mice [111]. A human study also showed an inverse correlation 
between Bacteroidetes abundance and body weight [111]. Members from Firmicutes 
(such as Ruminococcaceae, Lachnospiraceae, Clostridium, and Lactococcus) and 
Bacteroidetes (such as Prevotella, Bacteroides, and S24-7) have been frequently studied 
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in terms of their potential contributions to the development of obesity. Consumption of 
wholes foods had anti-obesity effects and also resulted in decreases in the abundance of 
Firmicutes and its members and increases in the abundance of Bacteroidetes and its 
members in obese mice, for example, the decreased abundance of  Ruminococcus gnavus 
by navy bean [112] and Clostridium by tomato and pomegranate juice [113], and the 
increased abundance of Bacteroides by lingonberry and strawberry [114-116], Prevotella 
and S24-7 by cherry, lingonberry and navy bean [59, 112, 117].  
Although the lowered F/B ratio has been widely used to indicate an anti-obesity 
profile of gut microbiota, it is worth mentioning that emerging evidence has supported 
the use of other microbiota-related markers to characterize obesity status. Opposite to the 
expected low F/B ratio in lean individuals, a human study showed a lowered F/B ratio in 
overweight and obese individuals in comparison to that of lean individuals [118]. Fibers 
can be fermented by both Firmicutes and Bacteroidetes, such as Lactobacillus and 
Ruminococcus from Firmicutes, and Prevotella and S24-7 from Bacteroidetes [119, 120], 
thus both Firmicutes and Bacteroidetes could thrive at the presence of fiber-rich whole 
foods. For example, oral administration of mushroom powders inhibited obesity in mice, 
but it did not lower the F/B ratio [121]. This may be due to the increase of the abundance 
of Firmicutes genera Lactobacillus, Lactococcus and Ruminococcus at the presence of 
mushroom fibers [121]. Avocado and bitter melon-fed obese rats significantly lost body 
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weight, but they did not show a lowered F/B ratio in comparison with the obese rats [60, 
122]. These results supported the use of markers other than the F/B ratio to indicate an 
anti-obesity microbiota profile. For example, Prevotella-to-Bacteroides ratio was used to 
predict the success in weight loss in humans [123]. Interestingly, the amount of fecal 
SCFAs has been considered as a marker of obesity in humans because that colonic 
production of SCFAs correlated well with the BMI and the levels of SCFAs are in 
accordance with the alteration of gut bacteria [118, 124].  
As shown in Table 2, Akkermansia, a Gram-negative bacterium belonging to 
Verrucomicrobia, has attracted increasing attention in terms of its role in obesity. Calorie 
restriction followed by a weight-stabilizing diet improved metabolism status of 
overweight and obese volunteers, which was accompanied by higher fecal abundance of 
Akkermansia muciniphila [125]. The fecal abundance of Akkermansia muciniphila 
inversely correlated with body weight of rodents and humans, and the oral administration 
of Akkermansia muciniphila alleviated high-fat diet-induced metabolic disorder, such as 
increased fat-mass, inflammation in adipose tissue, metabolomic endotoxemia, and 
insulin resistance  [59, 112, 117]. Importantly, obesity was associated with the reduced 
mucus thickness in mouse intestinal tract [126], suggesting the increased gut 
permeability. Akkermansia muciniphila administration in obese mice restored the 
thickness of mucus, thus enhancing the gut barrier function, as well as improving glucose 
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homeostasis and adipose tissue metabolism [126]. Interestingly, a protein named 
Amuc_1100, isolated from outer membrane of Akkermansia muciniphila, was capable of 
recapitulating the beneficial effects of Akkermansia muciniphila through the interaction 
with Toll -like receptor 2 to improve gut barrier [127].  
Consumption of whole fruits and vegetables were found to increase the 
abundance of Akkermansia muciniphila. For example, oral intake of cherry [117], 
lingonberry [59, 115, 116], grape [128], mango [129], or navy bean [112] in obese mice 
decreased body weight and increased the fecal abundance of Akkermansia muciniphila, 
indicating that anti-obesity actions of these whole fruits and vegetables might be closely 
related to their effects in promoting the growth of Akkermansia muciniphila. The high 
levels of fibers in these whole foods might contribute to the blooming of Akkermansia 
muciniphila in the colon [130]. Furthermore, dietary polyphenols from fruits also could 
promote the growth of Akkermansia muciniphila in the colon, which was associated with 
their anti-obesity and anti-colonic inflammation potential [131]. 
30 
 
Table 2. The effects of whole fruits and vegetables on gut microbiota in obesity models 
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[113] 
(IL, interleukin; HOMA-IR, homeostatic model assessment for insulin resistance; TNF, tumor necrosis factor; MCP, monocyte 
chemoattractant protein; NLRP, Nod-like receptor protein; TG, triglyceride; ZO-1, zonula occludens-1; LBP, LPS-binding protein; 




2.3.2 Colonic Inflammation 
In the host, homeostasis of gut microbiota is required to maintain health. When 
the balance of bacterial community in the colon becomes disrupted, it may trigger 
abnormal immune responses and induce colonic inflammation [138]. For example, 
certain species of bacteria were considered the stimuli to the colonic inflammation, and 
the increase in these bacteria, e.g. pathogenic E. coli, was strongly associated with 
colonic inflammation [139]. On the other hand, several strains of Bifidobacterium and 
Lactobacillus can produce anti-inflammatory effects by modulating the inflammation 
related cell signaling pathways [140], and the ample presence of these bacteria in the gut 
may protect the host against colonic inflammation. Colonic inflammation was associated 
with the reduction of Firmicutes [141], Bacteroides [141], Bifidobacterium adolescentis 
[142], Faecalibacterium prausnitzii [141], Lactobacillus and Eubacterium [143], and the 
increase in Enterobacteriaceae and Ruminococcus gnavus [142, 144]. Studies have 
supported the notion that whole fruits and vegetables inhibit colonic inflammation via 
modulating related bacteria. Administration of whole cranberry powder or strawberry 
powder in the diet of dextran sulfate sodium-treated mice for 6 weeks increased fecal 
abundance of Lactobacillus and Bifidobacterium, which was associated with suppression 
of colonic inflammation [145-147]. In a genetically induced colitis mouse model, dietary 
consumption of blueberry or broccoli powder (10% w/w in diet) remarkably reduced the 
abundance of Clostridium perfringens and Escherichia coli [148]. These bacteria were 
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positively associated with colonic inflammation [139, 149]. The anti-inflammatory 
potential of whole foods in the colon could stem from (i) the bioactive components in the 
whole foods, (ii) altered gut microbiota induced by the whole foods, and/or (iii) 
microbiota-derived metabolites of whole food components. For example, Anthocyanin-
rich fractions from red raspberry showed anti-inflammatory effects against LPS-induced 
inflammation in macrophages, which was evidenced by the suppression of NO synthesis, 
as well as the downregulation of iNOS, COX-2, IL-1β and IL-6 [150]. Probiotic 
Bifidobacterium could suppress inflammation both in vitro and in vivo [151, 152]. 
Fermentation of MACs from whole foods by gut bacteria produces SCFAs, especially 
butyrate, that showed anti-inflammatory effect through inhibition of NFB pathway and 
regulation of T cell functions [153, 154]. It is noteworthy that these three modes of 
actions often coexist in the colon and are likely to interact with each other, therefore, 
produce modified health outcomes in comparison with that produced by each mode of 
action alone. Recently, an increasing number of studies demonstrated the anti-colonic 
inflammation effects of whole fruits and vegetables, such as cranberry, strawberry, 
mushroom, and anthocyanins-containing potatoes [52, 145, 147, 155, 156]. However, the 
detailed mechanistic understanding of how whole food components and gut microbiota 
interact to produce inhibitory effects against colonic inflammation is lacking, therefore 
warrants further investigation. 
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Probiotics, such as Bifidobacteria and Saccharomyces, have been shown to offer 
protective effects against colonic inflammation [152]. Moreover, probiotics supplemented 
with food components might produce synergistic effects to confer benefits to the host. 
For example, a synbiotic supplementation, which contained whole plant sugar cane fiber 
and Bacillus coagulans, induced a stronger suppression on colonic inflammation than 
either whole plant sugar cane or Bacillus coagulans alone [157]. Akkermansia, an 
emerging probiotic has demonstrated anti-inflammatory effects in the colon via 
stimulating mucin production and improving gut barrier [126, 158, 159]. Patients with 
colonic inflammation showed a lower fecal abundance of Akkermansia [160]. Oral 
administration of Akkermansia to dextran sulfate sodium-treated mice ameliorated 
colonic inflammation, which was evidenced by the lower colon histological score and 
reduced colonic levels of pro-inflammatory cytokines [161].  
Although Akkermansia showed consistent protective effects against obesity and 
diabetes, the role of Akkermansia in colonic inflammation remains controversy. For 
example, higher abundance of Akkermansia has been found in patients with IBD and 
colitic mice in comparison to the corresponding healthy counterparts [162-164]. An 
possible explanation is that decreased thickness of mucus layer in the inflamed colon led 
to the outgrowth of Akkermansia [165], consequently, the growth of Akkermansia in the 
lumen is elevated due to its access to ample substrates in the stool [166]. In line with 
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these findings, colitic mice had a high fecal abundance of Akkermansia than non-colitic 
mice, and consumption of whole strawberry or cranberry inhibited the colonic 
inflammation and decreased the fecal abundance of Akkermansia [145, 147]. It is possible 
that the protective effects of whole berries against colonic inflammation maintained 
integrity of the colonic tissue, which in turn prevented migration of Akkermansia from  
mucus to the lumen [117]. A recent study showed that oral administration of Akkermansia 
muciniphila induced colitis in germ-free IL10-/- mice by degrading mucus and producing 
LPS in the colon [167]. This finding was opposite to that of another report, where oral 
gavage of Akkermansia muciniphila inhibited colitis in mice [161]. Different cellular 
components of Akkermansia were found to exert distinct functions in colon health. For 
example, the outer membrane of Akkermansia was reported to induce inflammation by 
upregulating the pro-inflammatory cytokines (IL-1β and IL-6) in bone-marrow-derived 
macrophage [167], whereas, Amuc_1100 protein, isolated from outer membrane of 
Akkermansia, was able to improve gut barrier in high fat-fed mice [127]. These findings 




NON-EXTRACTABLE POLYPHENOLS FROM CRANBERRY: A POTENTIAL 
ANTI-INFLAMMATION AND ANTI-COLON CANCER AGENT 
3.1 Introduction 
Polyphenols are a major class of dietary phytochemicals which are responsible for 
many health benefits. Current research on dietary polyphenols mainly focus on a fraction 
of polyphenols, known as extractable polyphenols (EP) [15, 16]. EP can be extracted 
from food with aqueous-organic solvents (e.g. water, methanol, ethanol, acetone) [17, 
18], and are often considered as “total phenolic content” for various biological studies. 
However, another fraction of polyphenols remains in the residues after solvent extraction, 
and they are known as non-extractable polyphenols (NEP) [16, 19]. NEP are mainly 
polyphenols that bound to dietary fiber or other macromolecules through hydrophobic 
interaction, hydrogen bonding and covalent bonding [15, 16]. NEP is not significantly 
released from the food matrix during digestion in the stomach or small intestine, therefor 
they reach colon nearly intact [20]. In the colon, NEP may be released from food matrix 
by the action of microbiota and become bioavailable and bioactive. In contrast, EP tend 
to be absorbed and metabolized in the upper gastrointestinal tract, therefore, their 
biological fate is quite different from that of NEP. Only unabsorbed EP and their 
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metabolites could reach the colon. The better colonic bioavailability of NEP than EP 
makes NEP promising candidates for promoting colon health.  
Colon diseases such as inflammatory bowel diseases (ulcerative colitis and 
Crohn’s disease) and colon cancer have posed serious threats to the human health. Colon 
cancer is one of the leading causes of death in both of male and female in the United 
States, and colitis is a key risk factor for colon carcinogenesis [168, 169]. The prevention 
of colon cancer is the most logical method to controlling it, which is suggested by 
accumulating evidence [170, 171]. Berries and their components have been subject of 
many studies for the anti-inflammatory and anticancer effects. Cell culture studies have 
demonstrated the inhibitory effects on human colon cancer cells by the extracts of various 
berries such as blackberry, black raspberry, red raspberry, blueberry, cowberry [17]. 
Berries (e.g. chokeberry, red raspberry, strawberry, cowberry) and their extracts have 
been shown to have anti-inflammatory and anticancer effects in the intestine of various 
animal models such as AOM-induced rat colon cancer model, Apc 1638+/- mouse and 
Muc2-/- mouse model, and DSS-induced colitis models [12, 14, 156]. 
Cranberry is a native berry fruit of North America, and it is abundant of 
polyphenols including flavan 3-ols, proanthocyanidins, anthocyanins and phenolic acids 
[21]. Majority of studies on cranberry have been focused on its antibacterial actions [22]. 
To date, the inhibitory effects of cranberry on colonic inflammation and colon cancer 
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have not been adequately studied. Cranberry extracts have been shown to inhibit colon 
cancer cell growth and suppress pro-inflammatory enzymes expression [21]. However, 
most published studies focused on EP of cranberry, and NEP has been neglected. The 
object of this study is to characterize EP and NEP fractions from cranberry and determine 
their potential in anti-inflammation and anti-colon cancer. 
3.2 Materials and methods 
3.2.1 Materials 
Cranberry (Early Black variety) was harvested at State Bog, Wareham, MA 
(September 2011), and whole cranberry powder was obtained by freeze-drying from fresh 
cranberry fruits. The freeze-dried whole cranberry powder is deep red in color and free-
flowing. procyanidin B2, procyanidin A2, cyanidin 3-arabinoside, peonidin 3-glucoside 
were from Shyuanye (Shanghai, China). Myricetrin, astragalin, myricetin, quercetin, ρ-
coumaric acid, ferulic acid, protocatechuic acid, chlorogenic acid, caffeic acid, and benzoic 
acid were from Quality Phytochmicals, LLC (Ease Brunswick, NJ). 
3.2.2 Extraction of EP 
100g freeze-dried cranberry powder was mixed with 70% (v/v) acetone aqueous 
(1% acetic acid). The mixture was sonicated for 30 min at room temperature, and the 
supernatant was collected after centrifuging at 4000 g for 5 min. The residues were 
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extracted twice more, pooled the supernatants. The supernatant was concentrated and 
then dissolved in methanol. Hexane was used to remove fat and other highly lipophilic 
molecules in extracts, after which the supernatant was concentrated at 40 ℃ to dryness. 
EP fraction was collected and stored in -20 ℃ for further studies. 
3.2.3 Extraction of NEP 
The residues obtained after EP fractionation were treated with 2 M NaOH at 
37 ℃ for 2 h after purging container with nitrogen to protect polyphenols from oxidation. 
After alkaline hydrolysis, mixture was adjusted to pH 2 with 6 M HCl, centrifuged at 
4000 g for 10 min to obtain supernatant. The supernatant was extracted by ethyl acetate 
and diethyl ether (1:1, v/v) for three times. The Pooled supernatants were concentrated to 
dryness under vacuum. The NEP fraction was collected and stored in -20 ℃ for further 
studies. 
3.2.4 Determination of total phenolic contents (TPC), flavonoid contents (FC), tannin 
contents (TC), and ORAC 
TPC was measured using the Folin-Ciocalteu method with some modifications 
[172]. Sample was dissolved in 50% methanol at the final concentration 0.4 mg/mL. 
Twenty µL Folin-Ciocalteu reagent was added to a 96-well plate containing 20 µL sample 
and 20 µL distilled water. The plate was tapped gently on all sides and kept at room 
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temperature for 10 min, followed by addition of 140 µL 7% sodium carbonate. After 90 
min at room temperature, the absorbance was measured at 760 nm (BioTek Instrument, 
Inc. Vermont, VT, USA). Results are expressed as microgram of gallic acid equivalents 
per gram.  
FC was determined as previously described with some modifications [173]. 
Briefly, 20 µL 0.4 mg/mL sample was mixed with 100 µL distilled water and 10 µL 5% 
sodium nitrite in a 96-well plate. After 6 min, 20 µL 10% aluminum chloride was added 
in the mixture and allowed to react for 5 min. Subsequently, 50 µL 1 M sodium 
hydroxide was added in the mixture. Tap the plate gently on all sides for 2 min, and the 
absorbance was read at 510 nm (BioTek Instrument, Inc. Vermont, VT, USA). The results 
are expressed as microgram of catechin equivalents per gram. 
 TC was tested as previously described with modifications [174]. The vanillin- 
H2SO4 solution was made of 4% vanillin in methanol and 30% H2SO4 in methanol in the 
ratio of 1:1. One hundred eighty µL vanillin-H2SO4 solution was added in a 96-well plate 
containing 20 µL 0.4 mg/mL sample. The absorbance was determined at 510 nm (BioTek 
Instrument, Inc. Vermont, VT, USA), and results are expressed as microgram of catechin 
equivalents per gram.  
The antioxidant capacity was determined by ORAC assay following the 
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previously published method with modifications using microplate reader (BioTek 
Instrument, Inc. Vermont, VT, USA) [175]. 
3.2.5 LC-MS analysis 
Identification and quantification of selected flavonols, flavanols, anthocyanins 
and phenolic acids were carried out by LC-MS as described preciously with some 
modification [176]. Chromatographic separation of anthocyanins was carried out on 
Zorbax SB-Aq C18 column (150 mm ×4.6 mm, 5μm, Agilent Technologies, USA). 
Separation of flavonols, flavan 3-ols and phenolic acids were achieved on Kinetex XB-
C18 column (100 mm ×4.6 mm, 2.6 μm, Phenomenex, Torrance, CA, USA). The mobile 
phase consisted of 0.1% formic acid in 95% water mixed with 5% ACN (solvent A), and 
0.1% formic acid in ACN (solvent B). The elution program processed as follows: 0-2 
min, isocratic elution with 5% B; 2-37 min, 5-95% B; 37-40 min, 95-100% B; 40-46 min, 
100-5% B; 46-52 min, isocratic elution with 5% B. The flow rate was 0.4 mL/min, and 
injection volume was 10 µL. Proanthocyanidins B2, proanthocyanidins A2, ECG, 
myricetrin, astragalin, myricetin, p-coumaric acid, ferulic acid, protocatechuic acid, 
chlorogenic acid, caffeic acid, benzoic acid, cyanidin 3-arabinoside, peonidin 3-glucoside 
were used as external standards. 
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3.2.6 Determination of cell viability, colony formation, cell cycle and apoptosis 
Assays for cell viability, colony formation, cell cycle and apoptosis were 
performed as we previously described [177-180]. In brief, HCT116 cells were purchased 
from the American Type Culture Collection (ATCC, Rockville, MD, USA). HCT116 
(2,500 cells/well) were cultured in RPMI-1640 media supplemented with 5% heat-
inactivated FBS, 100 units/mL of penicillin, and 0.1 mg/mL of streptomycin (Mediatech, 
Herndon, VA) at 37 ℃ with 5% CO2 and 95% relative water humidity. After 24 hours of 
attachment, cells were treated with serial concentrations of EP and NEP for 24 h, then cell 
viability was determined by MTT assay [177].  
HCT116 (400 cells/well) were seeded in 6-well plates. After 24 hours attachment, 
cells were subjected to the treatment of serial concentration of EP and NEP. The media in 
6-well plate were refreshed every 2 days. After 14 days, the determination of colony 
formation was conducted as we described previously [180].  
HCT116 (4 × 104 cells/well) were seeded in 6-well plates for cell cycle and 
apoptosis analysis. After 24 hours of incubation and attachment, cells were treated with 16 
µg (GAE)/mL NEP for 24 h, and then cells were collected by brief trypsinization (0.25% 
trypsin-EDTA; Mediatech)for analysis by flow cytometry to determine cell cycle or 
apoptosis [177, 180]. 
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3.2.7 Nitric oxide assay and immunoblotting 
RAW 264.7 were purchased from the American Type Culture Collection (ATCC, 
Rockville, MD, USA). RAW 264.7 cells were cultured in RPMI-1640 media 
supplemented with 10% heat-inactivated FBS (Medistech, Herndon, VA, USA), 100 
units/mL of penicillin, and 0.1 mg/mL of streptomycin (Sigma-Aldrich, St. Louis, MO, 
USA) at 37 ℃ with 5% CO2 and 95% air. Griess reaction was used to determine the 
concentration of nitrite in the culture media, which is an indicator of NO production 
[181]. RAW264.7 cells (5 × 105) were seeded in 96-well plates. After 24 hours, cells were 
treated with different concentrations of EP or NEP for 24 hours. After 24 hours treatment, 
the media were mixed with an equal volume of Griess reagent mixture (reagent A: 1% 
sulfanilamide in 5% phosphoric acid, reagent B: 0.1% naphthylethylenediamine 
dihydrocholoride aqueous). Then the production of NO was determined at 540nm with a 
plate reader. 
Whole cell lysate from macrophages was extracted as we reported previously [177-
179, 182]. Briefly, RAW 264.7 cells (2.5 × 105 cells/mL) were cultured in cell culture dishes. 
After 24 h attachment, the media were replaced by 1µg/mL lipopolysaccharides (LPS) with 
or without serial concentration of NEP. After 24 h, cell lysate was collected and subject to 
western blot analysis as we did previously [182]. 
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3.2.8 Data Analysis 
All results were presented as mean ±SD. Analysis of variance (ANOVA) was used 
to compare the differences among two or more groups. ρ< 0.05 was considered to be 
statistical significance. 
3.3 RESULTS AND DISCUSSION  
3.3.1 EP and NEP in cranberry 
Acetone and acetone aqueous are commonly used to extract polyphenols from fruits 
and vegetables. It was reported that acidic acetone was more effective in extracting 
polyphenols such as anthocyanins, flavan-3-ols and phenolic acids, than other solvents [18]. 
In order to increase the extraction rate of phenolic conjugates (e.g. β-glycosides), 70% 
acetone aqueous with 1% acetic acid was used to extract EP from cranberry (the yoeld of 
EP is 25,610 mg/100g dry powder) [183]. Alkaline hydrolysis was used to release NEP 
because it could release more NEP from plant matrix than acid hydrolysis or enzyme 
hydrolysis (the yield of NEP is 3,559.5 mg/100g dry powder) [184]. TPC, FC and TC of 
EP and NEP were shown in Figure 2. In general, EP had higher TPC, FC and TC than NEP. 
NEP content of cereals was found to be higher than that of EP [19, 185], while fruits had 
higher contents of EP than NEP [186]. The relative abundance of NEP vs. EP in cranberry 
was in consistence with the findings of previous studies about NEP from different fruits 
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including apple, orange, banana and grape [16, 187]. Both EP and NEP were more abundant 
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Figure. 2 Total phenolic content (TPC), flavonoid content (FC), and tannin content (TC) 
of EP and NEP fractions of cranberry. (GAE: gallic acid equivalents; CE: (+)-catechin 












1 0 0 0
1 2 0 0


























Figure. 3 Oxygen radical absorbance capacity (ORAC) of EP and NEP (TE: Trolox 
equivalents). Data represent mean ± SD (n=6), ** indicates p<0.01. 
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3.3.2 Chemical profiles of EP and NEP  
The chemical profiles of EP and NEP were determined by HPLC-MS, results 
were presented in Table 3. Majority of the phenolic compounds identified by comparing 
their retention times and fragmentation patterns with those of standards occurred in both 
EP and NEP, for example procyanidin A2, myricitrin, astragalin, p-coumaric acid, 
protocatechuic acid, chlorogenic acid and benzoic acid. In EP fraction, the main 
constituents were anthocyanins, including cyanidin-3-arabinoside and peonidin-3-
glucoside, whereas anthocyanins were not found in NEP fraction. The major components 
in NEP were phenolic acids, including chlorogenic acid, p-coumaric acid, ferulic acid, 
caffeic acid, protocatechuic acid and benzoic acid, and the total content of phenolic acids 
was more than 10 times higher than that of EP. Meanwhile, all the phenolic acids 
described above were found in NEP of cranberry for the first time, although some of 
them have been previously found in EP fraction of cranberry [188]. Previous studies 
reported that cranberry was abundant of proanthocyanidins that contributed to various 
health benefits, especially those with unusual A-type linkages [189, 190]. Importantly, 
proanthocyanidins were also found in NEP fraction, and their abundance was higher than 
that in EP. Although the major polyphenols in NEP were phenolic acids, other kinds of 
flavonoids were also found in NEP, such as myricitrin, myricetin, and astragalin. 
Although alkaline hydrolysis has been frequently used to release phenolics from fiber, it 
also can break the esters and glycoside linkages of phenolic components after the release, 
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which is a factor to be considered when interpreting the chemical profiles of NEP 
fraction. Proanthocyanidins or condensed tannins have been reported in EP from 
cranberry [191]. Interestingly, our results showed the existence of tannins in cranberry 
NEP and their abundance was much higher than EP, especially procyanidin A2 as shown 
in Table 3.  
3.3.3 Antioxidant capacity of EP and NEP 
ORAC was used to determine the antioxidant capacity of EP and NEP. EP and 
NEP showed ORAC values of 984.17 μmol TE/g(extract) and 1258.53 μmol 
TE/g(extract), respectively (Fig.3). The abundance of anthocyanins, flavanols, flavonols 
and phenolic acids in EP fraction might contribute to the antioxidant capacity, especially 
anthocyanins (e.g., cyanidin 3-arabinoside and peonidin 3-glucoside) which have been 
reported for their antioxidant capacity (Table 3) [192]. Notably, phenolic acids were the 
dominant phenolic constituents in NEP (Table 3), and they may responsible for the 
antioxidant capacity of NEP [193]. Importantly, the major compounds reported in urine 
after the consumption of berries were phenolic acids [81, 194], increasing numbers of 
studies have been focused on the phenolic acids produced from the metabolism of food 
components and their contribution to the human health. 
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3.3.4 Anti-inflammatory effects of EP and NEP in RAW264.7 macrophages 
To determine the anti-inflammatory effects of EP and NEP, their effects on the 
growth of RAW264.7 macrophages were firstly determined by cell viability assay. 
Neither EP nor NEP showed cellular toxicity at the concentration range of 2 -16 µg gallic 
acid equivalent (GAE)/mL (data not shown). After establishing the nontoxic 
concentration range, the effects of EP and NEP on nitric oxide (NO) production induced 




Time MS (m/z) NEP (mg/g extract) EP (mg/g extract) 
 
procyanidin B2 8.99  579[M+H]
＋ N 0.09 ± 0.02 
 
procyanidin A2 10.15  577[M+H]
＋ 1.12 ± 0.23 0.40 ± 0.00 
 
ECG 9.98  443[M+H]
＋ 0.18 ± 0.06 0.13 ± 0.00 
 
myricetrin  9.60  463[M+H]
＋ 1.09 ± 0.20 0.81 ± 0.02 
 
astragalin  10.10  447[M+H]
＋ 0.58 ± 0.12 0.20 ± 0.01 
 
myricetin  11.50  319[M+H]
＋ 0.15 ± 0.02 N 
 
quercetin 22.72 303[M+H]
＋ 0.16 ± 0.01 0.18 ± 0.06 
 
total flavonols and flavanols   3.28  1.81  
 
     
 
cyanidin 3-arabinoside 26.01  420[M+H]
＋ N 1.79 ± 0.07 
 
cyanidin 3-galactoside 30.86 450[M+H]
＋ N 2.10 ± 0.04 
 
peonidin 3-galactoside 22.99 464[M+H]
＋ N 5.43 ± 0.12 
 
peonidin 3-glucoside 26.74  464[M+H]
＋ N 1.95 ± 0.18 
 
total anthocyanins    11.27  
 
     
 
p-coumaric acid  27.02  165[M+H]
＋ 4.52 ± 0.11 0.31 ± 0.12 
 
ferulic acid 27.30  195[M+H]
＋ 0.33 ± 0.01 N 
 
protocatechuic acid  21.20  153[M-H]- 0.46 ± 0.02 0.16 ± 0.04 
 
chlorogenic acid 21.53  355[M+H]
＋ 10.54 ± 0.29 0.33 ± 0.13 
 
caffeic acid  24.30  181[M+H]
＋ 0.37 ± 0.04 N 
 
benzoic acid 7.16  123[M+H]
＋ 0.10 ± 0.03 0.66 ± 0.11 
 
total phenolic acids     16.31  1.46   
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by LPS (1µg/mL) in macrophages were determined. NO is an important inflammation 
mediator whose production can be induced by LPS. As shown in Figure 4, at 4 and 8 µg 
GAE/mL, EP treatment showed 15% inhibition of the production of NO in comparison 
with the LPS-treated positive control group. Although NEP caused similar suppression as 
EP on NO production at 4 µg GAE/mL, NEP markedly lowered the production of NO by 
32% at 8 µg GAE/mL, when compared to the positive control group. At 16 µg GAE/mL, 
NEP caused 53% inhibition on NO production, while EP at the same concentration 
inhibited the production of NO by only 12%, when compared to the positive control. The 
difference between EP and NEP in terms of the suppression of NO production is expected 
to be due to their different chemical profiles. For example, higher levels of phenolic acids 
including chlorogenic and p-coumaric acids in NEP may contribute to the higher anti-
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Figure. 4 Effects of EP and NEP on LPS-induced nitric oxide production in RAW 264.7 
macrophages. The cells were treated with or without 1 µg/mL LPS or LPS plus different 
concentrations of EP and NEP fractions for 24 hours. Then the media was collected and 
determined the NO production as described in Materials and Methods. Results were 
expressed as mean ± SD (n=6). *p< 0.05 and **p<0.01 indicate statistical significance, 
when compared to LPS treatment group. 
Since NEP had much stronger inhibitory effects than EP on NO production in 
RAW 264.7 macrophages, we further investigated molecular mechanism by which NEP 
inhibited NO production. Inducible nitric oxide synthase (iNOS) is one of the important 
pro-inflammatory proteins [182]. The expression of iNOS was very low without LPS 
treatment, while LPS treatment significantly increased iNOS expression by 22.7-fold 
(Figure 5A). NEP showed a dose dependent inhibition on the expression of iNOS, and 
NEP at 8 and 12 µg GAE/mL significantly suppressed expression levels of iNOS by 68% 
and 84%, respectively (Figure 4A). We examined expression levels of nuclear p50 and p-
IκBα, both of which play critical role in the mediation of inflammation. p50 is the 
functional subunit of NF-κB pathway, and phosphorylation of IκBα results in dissociation 
of IκBα from NF-κB, and activated NF-κB initiates pro-inflammatory responses [182]. 
The results demonstrated a dose dependent inhibition on the expression of nuclear p50 by 
NEP, and especially, NEP at 8 and 12 µg GAE/mL decreased the levels of nuclear p50 by 
more than 80% when compared to that of LPS-stimulated positive control cells (Figure 
5B). Also, expression levels of p-IκBα were suppressed by NEP treatment at 8 and 12 µg 
GAE/mL. We further determined the effects of NEP on the expression levels of HO-1, an 
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antioxidant enzyme, which involves in the inflammation. HO-1 expression contributes to 
the adaptive increase of cellular anti-oxidant capacity, and it is important targets for anti-
inflammation remedy [181]. Results indicated that NEP treatment caused a dose-
dependent increase in the expression of HO-1, especially, at 8 and 12 µg GAE/mL NEP 
increased HO-1 expression by 4.2-fold and 6.7-fold compared to the LPS-treated positive 
control cells, respectively (Figure 5C). The expression levels of Nrf2, a transcription 
factor of HO-1 gene, which involves in the induction of HO-1, was significantly 




Figure. 5 Inhibitory effects of NEP on LPS-induced proteins expression of iNOS (A), p-
50, p-IκBα (B), HO-1 and Nrf2 (C) in RAW 264.7 macrophages. RAW 264.7 cells were 
seeded in culture plates for 24 h, and then treated with different concentrations of 
NEP.After 24 h, cells were collected for Western blotting analysis. The numbers 
underneath the blots represent band intensity that was normalized by β-actin (cytosolic 
fraction) or PARP (nuclear fraction). *p<0.05 and **p<0.01 indicate statistical 
significance in comparison with LPS-treated group (n=3). The standard deviations (all 
within ±15% of the means) were not shown. 
3.3.5 Anti-colon cancer effects of EP and NEP on human colon cancer cells 
Accumulating studies suggest that various polyphenols derived from fruits and 
vegetables possess anticancer effects in various models. As a rich resource of 
54 
 
polyphenols, EP and NEP from cranberry potentially also have anticancer capacity. NEP 
cannot be released from the food matrix in the stomach or small intestine, they reach 
colon nearly intact [20], where they may show biological benefits after being released 
from matrix by gut microbiota-mediated fermentation. Therefore, we determined the anti-
colon cancer potential of cranberry EP and NEP. Cell viability assay revealed that both 
EP and NEP showed inhibition on the growth of cancer cells. NEP had stronger 
inhibitory effects on the growth of human colon cancer HCT116 cells than EP at the 
concentration range of 2-16 µg GAE/mL, and NEP treatment showed a dose-dependent 
inhibition (Figure 6A). At the concentration of 16 µg GAE/mL, NEP and EP caused 
inhibition on cell viability by 20% and 60%, respectively.  In consistence with the cell 
viability assay, colony formation assay indicated that EP and NEP showed suppression 
on the colony formation of colon cancer cell. And NEP had stronger inhibitory effects on 
colony formation of colon cancer cells, for example, at 6 µg GAE/mL, NEP and EP 





Figure. 6 (A) Inhibitory effects of EP and NEP fractions on the viability of HCT116 
human colon cancer cells in MTT assay. HCT116 cells (2500 cells/well) were seeded in 
96-well plates for 24 h, and then treated with serial concentrations of EP and NEP. After 
24 h, cells were subjected to MTT assay. Data represent mean ± SD (n=6). (B) Inhibitory 
effects of NEP and EP fractions on the colony formation capacity of HCT116 cells. 
HCT116 (400 cells/well) were seeded in 6-well plates. After 24 hours, cells were 
subjected to the treatment of different concentrations of EP and NEP. The media in 6-well 
plate were refreshed every 2 days. After 14 days, the determination of colony formation 
was conducted. Data represent mean ± SD (n=3). (C)Images of colony formation 
ofHCT116 cells under different treatments. *p<0.05 and **p<0.01 indicate statistical 
significance in comparison with control group. 
Since NEP showed stronger inhibitory effects on the growth of the colon cancer 
cells in comparison with EP, we further investigated the mechanism by which NEP 
inhibit the colon cancer cell viability and colony formation. We determined the effects of 
NEP on cell cycle progression and cellular apoptosis of HCT116 cancer cells by flow 
cytometry as we described previously [180]. Based on results obtained from cell viability 
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and colony formation assay, we selected a NEP dose of 16 µg GAE/mL to determine its 
effects on cell cycle progression and apoptosis. The results revealed that NEP-treatment 
significantly increased the cell population in G0/G1 phase and decreased the cell 
population in S phase in comparison with the control, suggesting a cell cycle arrest at the 
G0/G1 phase (Figure 7A). After treatment with NEP, early and late apoptotic cell 
populations were increased by 3.8-fold and 6-fold, respectively, compared to the control 
group (Figure 7B). 
 
Figure. 7 Effects of NEP fraction from cranberry on cell cycle progression (A) and 
apoptosis (B) of HCT116 human colon cancer cells. HCT116 were seeded in 6-well 
plates for 24 h, then treated with or without 16 µg GAE/mL NEP. After 24 h treatment, 
cells were collected and subjected to cell cycle or apoptosis analysis with help of flow 
cytometry as described in Materials and Methods. * p<0.05 and **p<0.01 represent 
statistical significance in comparison with control group (n=6). 
In summary, this study provided an understanding of EP and NEP from cranberry 
in terms of their chemical properties and biological functions. Chemical profile of 
cranberry NEP was firstly determined, which showed that NEP possessed higher contents 
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of phenolic acids than EP. Meanwhile, NEP showed higher anti-oxidant capacity than EP 
(Fig.2). EP fraction in fruits have been extensively studied, such as their anti-oxidant, 
anti-inflammatory, anti-cancer, and antibacterial effects. However, reports about NEP 
have been scarce. NEP could bind to fiber and they may reach colon intact [15], so that 
the biological effects of NEP have been considered important for colon health. Our 
results indicated that both EP and NEP from cranberry had various biological effects. 
Importantly, NEP showed the promising anti-inflammatory and anti-cancer capacities. 
The high bioavailability of NEP in the colon facilitate the realization of these activities in 
the colnic tissues. Moreover, the potential interaction between gut microbiota and NEP 
could also play an important role in colon health. NEP could be biotransformed by gut 
microbiota to produce bioactive metabolites that may contribute to the promotion of 
colon health as well [197].  Therefore, it is important to investigate the interaction of gut 
microbiota and NEP in the colon in terms of production of bioactive metabolites. 
Meanwhile, composition and functions of gut microbiota can be altered by the presence 
of polyphenols in the colon, which in turn could affect colon health [198]. Unfortunately, 
the mode of interplay between NEP and gut microbiota in the colon is largely unknown, 
and much more efforts are needed to explore this promising research area. The 
knowledge obtained from our study is helpful for a better understanding of polyphenols 
in berries, especially the potential biological effects of NEP in the colon. Overall, this 
study provided the first line of evidence to support the notion that NEP could be a 
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promising beneficial agent for colon health. Certainly, further investigation is warranted 
to elucidate the detailed model of actions of NEP in the colon, especially in relationship 






NON-EXTRACTABLE PHENOLICS FROM STRAWBERRY: ANTI-
INFLAMMATION AND ANTICANCER POTENTIALS 
4.1. Introduction  
Strawberry is an important source of polyphenolic compounds, especially 
phenolic acids such as ferulic, p-coumaric, vanillic, caffeic, syringic, and sinapic acids 
and flavonoids [199]. Thus, strawberry has been popularly produced and consumed 
because of both as its delicious taste and health beneficial properties. Phenolics are 
important contributors to the diverse health benefits of strawberry including anti-
inflammation [200], anti-cancer [201], antioxidants and anti-diabetes [202]. In nature, 
phenolic compounds generally exist in the free and bound forms in plant cells. The free 
phenolic compounds are solvent extractable phenolics (EP). In contrast, the non-
extractable phenolic compounds (NEP), which are covalently bound to the plant matrix, 
cannot be extracted into water or aqueous/organic solvents mixtures [203]. NEPs are high 
molecular weight polymeric polyphenols or individual low molecular weight phenolics 
mainly cross-linking with macromolecules, such as polysaccharides, dietary fiber and 
proteins. They can be retained in the food matrix inaccessible to solvents due to different 
interactions with the plant matrix [204]. It is noteworthy that most of phenolics in 
strawberry are NEP [15]. The total phenolic compounds with anti-inflammation [200] and 
anti-cancer [201] property of strawberry have been reported, which lots of bibliographic 
information mainly involves the biological activities of EP present in the berries [205]. 
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Scarce information of NEPs on potential biological activities such as anti-inflammatory 
and anti-cancer are available [206, 207]. Although NEP is not available for extraction and 
absorption, they can be released under the low pH conditions of the gastrointestinal tract 
and upon colonic fermentation [208, 209]. Upon release, they can be absorbed in the gut 
lumen and exert a biological effect. Therefore, characterization of NEP and their anti-
inflammation and anti-cancer activity is of paramount importance to the understanding of 
the health benefits of strawberries. 
Colorectal cancer is the third most common cancer diagnosed in both men and 
women, and is one of the leading causes of death in the United States and worldwide 
[210]. Inflammatory bowel diseases play a key role in colon carcinogenesis. 
Consumption of fruits, vegetables and their bioactive constituents has been recommended 
to prevent colon cancer development. The health benefits of fruits and vegetables on 
reducing cancer risk are at least in part associated with the presence of unique 
polyphenolic compounds. 
In this study, we firstly aimed to determine the potential anti-inflammatory effects 
of NEP in LPS-stimulated RAW 264.7 cells, and the underlying mechanisms of action. 
Secondly, we sought to investigate the inhibitory activity of NEP in HCT-116 colon 
cancer cells, and its effects on cell cycle progression and apoptosis. 
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4.2. Material and methods  
4.2.1 Materials and Chemicals 
Strawberry powder was obtained from Ocean Spray, Inc. (Lakeville, MA, USA). 
Standards of phenolics such as ferulic acid, protocatechuic acid, chlorogenic acid, caffeic 
acid, benzoic acid,myricetrin, astragalin, myricetin and p-coumaric acid were purchased 
from Quality Phytochmicals, LLC (Ease Brunswick, NJ, USA). Antibody for β-actin, 
HO-1, iNOS and c-FOS were purchased from Cell Signaling Technology (Beverly, MA, 
USA). 3-(4, 5-dimethylthiazol-2-yl) -2, 5-diphenyltetrazolium bromide (MTT), 
propidium iodine (PI) and were purchased from Sigma-Aldrich (Natick, MA, USA). 
Annexing V/PI double staining was obtained from Bio vision (Mountain View, CA, 
USA). All chemical reagents used were of analytical grade. 
4.2.2 Extraction of NEP 
An ultrasonic-assisted extraction procedure was used for NEP [211]. Lyophilized 
strawberry powder (100 g) was mixed with 700 mL of 70% (v/v) acetone and then placed 
in an ultrasonic bath (300 Ultrasonik, Whittemore Enterprises, Inc., RanchoCucamonga, 
CA, USA) and sonicated at the maximum power for 30 min under refluxing conditions. 
After centrifugation of the resulting slurry for 5 min at 4000g (IEC Centra MP4, 
International Equipment Co., Needham Heights, MA, USA), the supernatant was 
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removed. Afterwards, the residues were subjected to extract NEP immediately [199].  
Residues were hydrolyzed with 2M sodium hydroxide (NaOH) at 37 oC for 2 h with 
stirring under nitrogen to protect phenolics from oxidation. The resulting slurry was 
acidified to pH 2 with 6M HCl and extracted three times with diethyl ether and ethyl 
acetate (1:1, v/v). Subsequently, supernatants were evaporated in vacuo at 4 oC (Buchi, 
Flawil, Switzerland), lyophilized for 72 h at -46 oC (Freezone, model 77530, Labconco 
Co., Kansas City, MO, USA) and stored at -20 oC until further analysis. During all stages, 
extracts were protected from light by covering them with aluminum foil. 
4.2.3 Determination of total phenolic content (TPC), flavonoid content (FC), tannin 
content (TC) 
TPC of strawberry extracts were determined using the Folin-Ciocalteu assay with 
some modifications [212]. Briefly, sample was dissolved in 50% methanol to final 
concentration 0.4 mg/mL. 20 µL of Folin-Ciocalteu reagents were added in 96-well plate 
containing 20 µL of sample and 20 µL of distilled water. After incubation at room 
temperature for 10 min, 140 µL of 7% sodium carbonate was added. The reaction was 
incubated at room temperature for 90 min, followed by absorbance measurement at 760 
nm using a spectrophotometer (BioTek Instrument, Inc. Winooski, VT, USA). Gallic acid 
was used as a standard, and TPC were expressed in milligram gallic acid equivalent (mg 
GAE/100g strawberry powder). 
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FC were determined by the aluminum colorimetric method and the catechin was 
used as standard [212]. 20 µL of 0.4 mg/mL sample was mixed with 100 µL distilled 
water and 10 µL of 5% sodium nitrite in 96-well plate. After 6-min incubation at room 
temperature, 20 µL of 10% aluminum chloride was added in the mixture and allowed to 
react for 5 min. Subsequently, 50 µL of 1 M NaOH was added in the mixture. After 
incubation at room temperature for 2 min, the absorbance was read at 510 nm using a 
spectrophotometer (BioTek Instrument, Inc.). The results are expressed as milligram of 
catechin equivalents per /100g strawberry powder (mg CE/100g powder). 
TC was tested according to the method described by Jackson with slight 
modifications [213]. Vanillin- H2SO4 solution was prepared by the ratio of 4% vanillin in 
methanol to 30% H2SO4 in methanol of 1:1. 180 µL of vanillin-H2SO4 solution was 
mixed with 20 µL of 0.4 mg/mL sample in 96-well plate. The absorbance was measured 
at 510 nm using a spectrophotometer (BioTek Instrument, Inc.), and results are expressed 
as milligram of catechin equivalents (mg CE/100g strawberry powder). 
4.2.4 Phenolics composition analysis 
Identification and quantification of flavonols, flavanols and phenolic acids were 
carried out by LC-MS as described preciously with some modification [214]. Separation 
of flavonols, flavan 3-ols and phenolic acids were achieved on Kinetex XB-C18 column 
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(100 mm ×4.6 mm, 2.6 μm, Phenomenex, Torrance, CA, USA). The mobile phase 
consisted of 0.1% formic acid in 95% water mixed with 5% acetonitrile (solvent A), and 
0.1% formic acid in acetonitrile (solvent B). The elution program processed as follows: 
5% B for 2 min, changed to 95% in 35 min, raised up to100% in 5 min, decreased to 5% 
B in 6min, kept 5% B in 6 min, the overall analysis time was 52 min. The flow rate was 
0.4 mL/min, and injection volume was 10 µL. ECG, myricetrin, astragalin, myricetin, p-
coumaric acid, ferulic acid, protocatechuic acid, chlorogenic acid, caffeic acid and 
benzoic acid were used as external standards, and limonin was used as internal standard. 
4.2.5 Cell viability, colony formation, cell cycle and apoptosis 
Cell viability, colony formation, cell cycle and cellular apoptosis were performed 
as our previously published method [215-218]. In brief, HCT-116 (2500 cells/well) and 
macrophages (AML-12, CCD-18, 12500 cells/well) were seeded in 96-well plates, 
respectively. Serum-starved cells were treated with serial concentrations of NEP for 24 h, 
then cell viability was determined by MTT method [216]. For colony formation analysis, 
HCT-116 was plated in 6-well plate at a density of 400 cells/well. After 24 hours, cells 
were treated with serial concentration of NEP. The medium in 6-well plate was refreshed 
every 2 days. After incubation for 14 days, the determination of colony formation was 
conducted as previously reported [217].  
For cell cycle analysis, HCT-116 was seeded in 6-well plates. After 24 hours of 
incubation, cells were treated with 20µg GAE/mL NEP. Cells were incubated for 24h and 
65 
 
subjected to analyze using flow cytometry with propidium iodide (PI) staining [218]. For 
apoptosis analysis, HCT-116 was treated with serial concentrations of NEP after seeded 
in 6-well plates. Then cells were incubated for 48 h and collected for analysis by flow 
cytometry [215]. 
4.2.6 Nitric Oxide (NO) assay 
LPS-induced NO production was conducted according to the method of used in 
our previous publication [219]. After 24 hours of RAW 264.7 cells seeding in 96 well 
plate (at the concentration of 50 ×104 cells/mL with 200 µL in each well), cells were 
treated with LPS (1µg/mL) together with testing compound for 24 hours followed by 
relatively measurement of nitrite concentration which is an indicator and a more stable 
product of NO. Briefly, 150µL of cell culture medium was mixed with 100µL of cold 
Griess reagent (2% sulfanilamide and 0.2% N-(1-naphthyl) ethylenediamine 
dihydrochloride in phosphoric acid), the mixture was incubated at room temperature for 
30 minutes, and the absorbance at 540 nm was measured in a microplate reader. Cell-free 
solution was used as a blank in every experiment. Percentage of nitric oxide inhibition 
was then relatively determined. 
4.2.7 Immunoblotting 
Whole cell lysate from macrophages was extracted and analyzed as previously 
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reported [217]. Briefly, RAW 264.7 cells were seeded in 10-cm culture dishes and 
incubated for 24 h to attach on dishes. Then, the fresh medium containing 1mg/mL LPS 
was replaced with or without serial concentrations of NEP. After 24 h, cell lysate was 
collected and subjected to western blot analysis as previously mentioned.  
4.2.8 Data Analysis 
All results were presented as mean ±SD for the indicated number of 
independently performed experiments. Student’s t-test and analysis of variance (ANOVA) 
were used to compare the differences among two or more groups, respectively. p< 0.05 
was considered statistically significantly difference. 
Table 4. Phenolic profiles of NEP of strawberry fractions identified by HPLC-MS.  





flavonols and flavanols    
ECG 9.98 443+ 0.310 ± 0.120 
EGCG 9.30 459+ 0.140 ± 0.110 
catechin 22.25 290+ 0.087 ± 0.008 
myricetrin 9.60 463+ 0.074 ± 0.020 
astragalin 10.10 447+ 3.500 ± 0.190 
myricetin 11.50 319+ 0.077 ± 0.013 
phenolic acids    
p-coumaric acid 27.02 165+ 23.560 ± 4.40 
ferulic acid 27.30 195+ 1.600 ± 0.420 
protocatechuic acid 21.20 153- 0.890 ± 0.180 
caffeic acid 24.30 181+ 5.100 ± 0.610 
benzoic acid 7.16 123+ 0.840 ± 0.250 




4.3 Results and discussion 
4.3.1 Phenolic profiles of NEP 
Regarding linkage and polymerization of NEP with protein and fiber, acidolytic 
method may partially release NEP. Thus, alkaline hydrolysis was conducted to release 
NEP by depolymerization and solubilization of cell walls [220, 221]. Figure 8 shows the 
total phenolic (TPC), flavonoids (FC) and tannin content (TC) of NEP fraction from 100 
gram lyophilize powder. TPC of NEP fraction was 295.04±5.28 mg GAE/100g powder, 
FC and TC of NEP fraction was 59.28±1.62 mg CE/100g and 52.66±0.49 mg CE/100g, 
respectively. Phenolic acids, flavonols and flavanols of NEP were detected using accurate 
mass and retention data (Table 4). Six compounds of flavonols and flavanols in NEP were 
identified as ECG, EGCG, catechin, myricetrin, astragalin and myricetin. Moreover, five 
phenolic acids were identified as p-coumaric acid, ferulic acid, protocatechuic acid, 
caffeic acid and benzoic acid. NEP contained high levels of p-coumaric acid (23.56 ±4.4 
mg/g extract), followed by caffeic acid (5.10 ±0.61 mg/g extract) and astragalin (3.50 
±0.19 mg/g extract). The phenolic profiles of NEP in the present study were partly in 
accordance with strawberry extractable phenolics in previous report by Aaby [222] due to 
ripening and growing conditions of strawberry cultivar, low stability and degradation of 
phenolics. Caffeic and coumaric acids have potential effects against lung and colon 
cancer development at adhesion and migration steps of tumor progression [223]. Because 
68 
 
NEP can be absorbed in the gut lumen and exert a biological effect upon their release by 
microbiota [224], NEP play an essential role in delivering phenolics to the colon and 
exhibiting biological activity. Thus, we further examined the anti-inflammation and anti-
cancer efficacy of NEP. 
 
Figure. 8 TPC, flavonoids (FC) and tannin content (TC) in strawberry non-extractable 
phenolic fractions (NEP) from 100 gram lyophilized powder. TPC was expressed as 
means ± SD (n=3) of gallic acid equivalent (GAE). FC and TC were expressed as means 
± SD (n=3) of catechin equivalent (CE). 
 
Figure. 9 Concentration-dependent inhibitory effect of NEP on LPS-induced NO 
production of RAW 264.7 cells. RAW 264.7 cells were exposed to NEP (16, 32, 48 and 
64 μg GAE/mL) with LPS (1.0 μg/mL) treatment. After 24 h of incubation, the amount of 
NO in the culture supernatants was measured by Griess reaction assay. Values are 



























































































LPS(1μg/mL)          -                   +                   +                  +                  +                 +              
NEP(μg GAE/mL)    -                    -                   16                 32                 48                64        
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ANOVA followed by Student’s t- test. ** p< 0.01 indicated significant differences in 
comparison to the LPS-treated group. 
4.3.2 Inhibition of LPS-induced NO production by NEP 
LPS-stimulated inflammatory models have been widely used to study the anti-
inflammatory activity of natural phenolics [225]. LPS can result in the release of pro-
inflammatory cytokines and activate nitric oxide (NO) cascades [200]. NO is an 
important fundamental component as a regulator and an effector molecule in many 
physiological and pathophysiological process. Using non-toxic dose range established, 
the effect of NEP on NO production induced by LPS (1µg/mL) in macrophages was 
examined. The untreated group was taken as control in RAW 264.7 macrophages. NEP 
treatment showed a notable reduction in the level of NO compared to control. As shown 
in Figure 9, NEP had dose-dependent inhibition on NO production. NO production was 
decreased to 68.65±5.33, 45.93±3.91, 26.95±5.68, and 21.55±1.81% at a dose range of 
16-64 µgGAE/mL. The result showed that NEP exhibited the efficacy against LPS-
induced damage in macrophages model.  
4.3.3 Immunoblotting analysis 
To investigate the molecular mechanism by which NEP inhibited inflammatory 
response in macrophages, we further determined the effects of NEP on the protein levels 
of iNOS, HO-1 and c-FOS by immunoblotting analysis. As shown in Figure 10, LPS 
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increased protein expression of iNOS, HO-1, and c-FOS. The protein expression of iNOS 
was decreased 11.8-fold by NEP treatment at 40 μg GAE/mL as compared to the LPS-
treated positive control group. HO-1 is an anti-oxidative enzyme that is associated with 
anti-inflammatory effects [219]. Treatments with NEP at 40 μg GAE/mL significantly 
increased the protein levels of HO-1 by 3.03-fold compared to the LPS-treated positive 
control cells. AP-1 is a critical transcription factor involved in the pro-inflammatory 
responses [226]. The effects of NEP on the levels of c-Fos, which is the key components 
of AP-1 protein complex, were investigated. LPS treatment did decrease the level of c-
Fos. These findings suggested that NEP might play a key role in preventing inflammation 
as a promising strategy by whole strawberry dietary intake. 
4.3.4 Anti-cancer effects of NEP in HCT-116 colon cancer cells 
To investigate anti-cancer effect of NEP, nontoxic dose range of NEP in alpha 
mouse liver 12 (AML-12) cells and normal colon cells (CCD-18) were firstly established. 
The cell viability was evaluated by MTT assay. NEP did not show significantly cellular 
toxicity at the concentrations from 0 to 60µg GAE/mL (Figure 11A). However, at the 
same concentration range, NEP dose-dependently inhibited HCT-116 cell growth, 
demonstrating a selective effect on cancer cells. As shown in Figure 4B, 60µg GAE/mL 





Figure. 10 Inhibitory effects of 40μg GAE/mL NEP treatment on LPS-induced protein 
expression of iNOS, c-FOS and HO-1 in RAW 264.7 macrophages. β-actin was served as 
an equal loading control.  
 
Figure. 11 (A): cell viability of alpha mouse liver 12 (AML-12) and normal colon cell 
(CCD-18) as normal cells treated with NEP. (B): concentration-dependent decrease in cell 
viability of HCT-116 colon cancer cells. Cells were treated with or without NEP under 
various concentrations for 24 h. Relative cell viability was assessed by MTT assay. The 
results were represented as percentage (mean± SD) of living cells compared to control. 
Comparisons of means were made using a one-way ANOVA followed by Student’s t-test 
(n =6). *p<0.05, **p<0.01indicated the significant differences in comparison to the 
control group. 
4.3.5 NEP suppresses colony formation of HCT-116 cells 
LPS          － ＋ ＋
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A strong association of inflammation with colon cancer has been well recognized 
[227]. Investing the anti-cancer potential of NEP is of great importance for better 
understanding the bioactivity of strawberry. To examine long-term suppressive effects of 
NEP treatment against the survival of HCT116 colon cancer cells, colony formation assay 
was performed. HCT116 colon cancer cells were exposed to a serial concentration of 
NEP for 14 days, using cells without NEP treatment as a control. As shown in Figure 12 
A and B, NEP showed dose-dependent inhibitory effects on the HCT-116 colony 
formation. The concentration of 1.25, 2.5, 5 and 10 μg GAE/mL reduced colony 
formation to 88.28±4.16, 79.69±6.08, 66.41±4.73 and 45.70±4.00, respectively in 
comparison to the control. Hence, NEP did cause long-term loss of survival of colon 
cancer cells [216]. The results were consistent with the cell viability that we obtained 
from the MTT assay. The results verified that NEP also poses significant anti-
proliferation effects of colon cancer, not merely the EP as mostly previous reports [228-
230].  




Figure. 12 Inhibitory effect of NEP on colony formation of HCT-116 human colon cancer 
cells. Cells were seeded 400 cells/well in six-well plates. After 24 h of incubation, cells 
were treated with serial concentrations of NEP. After 14 days of treatments, cells were 
dyed and scanned (A). The number of colonies formed was counted as described in the 
methods. Data represent means± SD, n=3 (B) all the treated groups showed significant 
difference in comparison to the control (*, p<0.05). 
Since many dietary phytochemicals have potential to inhibit carcinogenic process 
by interfering with one or multiple cellular pathways and play an important role in cancer 
chemoprevention [216]. To further understand the mechanism by which NEP inhibited 
colon cancer cell proliferation, using the concentration range lower than 60 µg GAE/mL, 
cell cycle distribution and cellular apoptosis were detected by flow cytometry. As shown 
in Figure 13, the cell population in G2/M phase of HCT-116 cells treated with NEP at 
20µg GAE/mL for 24 hours was significantly increased by 10% as compared to the 
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control cells, while the percentage of G1 phase cell population was 6% decreased and S 
phase was not changed in the present study (Figure 13A). It suggests DNA degradation 
by leading to cell death (Figure 13B). These results revealed that NEP could interrupt the 
cell cycle progression of colon cancer cells at the G2/M phase. 
 
Figure. 13 NEP induced G2/M cell cycle arrest in colon cancer cell line (HCT116) after 
24 hours exposure. (A): Percentage of cell population with and without 20 μg GAE/mL 
NEP treatment. DMSO was used in the negative control. Data represent means ± SD 
(n=3). *p <0.05 compared to the control. (B) and (C): PI-stained cells after NEP 20 μg 
GAE/mL treatment and DMSO, respectively, was analyzed by flow-cytometry. The 
percentage of cells in G0/G1, S and G2/M phase was calculated using Multicycle 
software. 
4.3.7 NEP induced cellular apoptosis in HCT-116 cells 
Next, we sought to determine the effect of NEP on cellular apoptosis in HCT116 
cells. Early and late apoptotic cells were quantified by Annexin-V/PI double staining in 
HCT-116 after 48 h treatment as we described previously [216]. Early apoptotic cells 
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(FITC-positive), viable cells (FITC-negative and PI-negative), late apoptotic and necrotic 
cells (PI-positive and FITC-positive) were monitored using flow cytometry. As shown in 
Figure 14A-14F, NEP at the concentration range of 10-40 µg GAE/mL did significantly 
induce cellular apoptosis in HCT-116 cells. Compared to the control (1.17%), NEP at 10, 
20, 30, 40µg GAE/mL markedly increased late apoptotic cells by 1.74- (from 1.17% to 
2.03%), 5.56- (from 1.17% to 6.50%), 10.06- (from 1.17% to 11.77%) and 48.23-fold 
(from 1.17% to 56.43), respectively. These results showed that NEP induced extensive 
cellular apoptosis of HCT116 cells, which would be an effective approach to control 
colon cancer progression. 
 
Figure. 14 Effect of NEP on HCT-116 cells apoptosis. (A-E), cells were treated with 
DMSO, 10, 20, 30, 40 μg GAE/mL NEP for 24 hours and subjected to flow cytometric 
analysis after PI and Annexin V staining. (F): percentage of cell population at different 
stages. All the treated groups showed significant difference in comparison to the controls 
(*, p<0.05; **, p<0.01). 
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4.4 Discussions  
Phenolic compounds of strawberry have been extensively studied due to their 
diverse health benefits as preventing chronic inflammation and cancer [231]. These 
biological effects are closely associated with their non-nutritional phenolic constitutes. In 
nature, phenolic compounds generally occur in two forms: one form is soluble extractable 
phenolics (EP), another form is insoluble bound phonics (NEP). Lots of literatures have 
demonstrated a wide range of biological activities of EP from millet, strawberry and 
mulberry [211, 231-234]. The bioactivities of NEP from strawberry and other fruits were 
scared [235]. Since NEP bound tightly with protein and fiber through hydrogen bonding 
and hydrophobic interactions [236], acid, alkali and enzymatic hydrolysis methods have 
been used to release NEP [209]. Thus the biological effects have been underestimated. In 
this study, we used alkaline hydrolysis to release NEP from cell wall matrix of strawberry 
powder. We found that NEP of strawberry mainly contained ECG, EGCG, catechin, 
myricetrin, astragalin, myricetin, p-coumaric acid, ferulic acid, protocatechuic acid, 
caffeic acid and benzoic acid. The phenolics constitutes were distinctly different from EP, 
which contained plentiful anthocyanins (Table 4). The result was consistent with reports 
described constituents of strawberry [237].   
It has been extensively elucidated that various soluble extractable phenolics (EP) 
inhibited to the growth of cancer cells by inducing cell cycle arrest and apoptosis, such as 
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EP from blackcurrant [238], blueberry and raspberry [239], purple and red corn [229]. It 
is well known that strawberry EP contribute greatly to the suppression of inflammation 
and colon cancer by strawberry [233], while the effects of NEP were unclear. NEP can be 
released by gut microbiota and subsequently well absorbed in vivo [240]. This prompted 
us to explore whether NEP exhibits the similar anti-inflammation and anti-cancer effect 
as EP. 
NEP was extracted from strawberry by alkaline hydrolysis in this study. Our result 
indicated that NEP at up to 60 µg GAE/mL showed significant inhibitory effect on HCT-
116 cells (Figure 11). Colony formation capability of colon cancer cells was also 
markedly suppressed by NEP at 10 µg GAE/mL (Figure 12). Induction of cell cycle arrest 
and cellular apoptosis in cancer cell is one of the effective strategies to control cancer 
progression. Mechanistic investigation suggested that strawberry NEP was effective in 
inducing colon cancer cellular apoptosis (Figure 14) and cell cycle arrest in G2/M phase 
(Figure 13) and thus suppressed cell proliferation of HCT116 cells (Figure 13). Our 
results at least partially enlarged the potent inhibitory activity of NEP on colon cancer. 
Further studies are planned to carry out on more cancer cells.  
Apoptosis is recognized to be activate mainly through the extrinsic death receptor 
pathway and the intrinsic mitochondrial pathway [241]. The intrinsic mitochondrial 
pathway is regulated by various intracellular signals, including the mitochondrial 
response. The release of mitochondrial proteins, such as cytochrome C, can activate the 
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caspase cascade that triggers cellular apoptosis [242]. Mitochondria have an key role in 
pro-inflammatory signaling; in turn, pro-inflammatory mediators may also alter 
mitochondrial function [243], Low grade and chronic inflammatory conditions can 
increase the risk of malignancy from epidemiological studies and molecular studies. 
Chronic inflammation exhibits tumor-promoting effects by various mechanisms, 
including enhancing proliferation of malignant cells and promoting tumor angiogenesis 
[219]. NO production not only is associated with the cell apoptosis, but also is an 
important signaling molecule involved in regulating inflammatory response [244]. The 
inflammatory response is characterized by coordinating activation of both pro- and anti- 
inflammatory mediators [245]. LPS is the leading stimulus that initiates the macrophages 
host response to release pro-inflammatory cytokines [246] and in turn activate a second 
level of inflammatory cascades including cytokines, lipid mediators and adhesion 
molecules such as NO [200]. Accumulating evidence suggests that phytochemistry plays 
a crucial role in suppressing inflammatory response [155]. In present study, NEP 
treatment can produce a significant suppression on NO production (Figure 9) and iNOS 
expression in RAW264.7 macrophage cells. The results is in line with the reports 
previously, in which the expression of inflammation marker iNOS was improved by 
strawberry EP [200]. It demonstrated that the strong association between NO production 
and iNOS expression.  
Recently, several phytochemistry studies have demonstrated that HO-1 plays a 
regulatory role in the inflammatory response by inhibiting production of pro-
inflammatory cytokines [200, 219]. HO-1 has been implicated in the maintenance of 
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cellular homeostasis and inhibition of the inflammatory response [246]. Herein, we 
observed that NEP induced the increase HO-1 in the RAW 246.7 cells, which also 
contributed to the anti-inflammatory effect.  
In conclusion, our findings suggested that NEP exerted powerful preventive 
ability against LPS-induced inflammation in macrophages, and inhibited the growth and 
proliferation of colon cancer cells via inducing G2/M phase cell cycle arrest and 
apoptosis. This information will provide important guidance for the chemoprevention 





DIETARY INTAKE OF WHOLE STRAWBERRY INHIBITED COLONIC 
INFLAMMATION IN DEXTRAN SULFATE DODIUM-TREATED MICE VIA 
RESTORING IMMUNE HOMEOSTASIS AND ALLEVIATING GUT 
MICROBIOTA DYSBIOSIS  
5.1 Introduction 
Inflammatory bowel disease (IBD) has posed serious threats to the human health 
[5], which lead to chronic malabsorption of nutrients, abnormal pain and rectal bleeding. 
Both genetic predisposition and environmental factors contribute to the onset of IBD [5, 
6]. Pathological immune response against exotic antigen and bacterial drives the 
progression of IBD [247]. Multiple studies suggested that dysbiosis in colon plays an 
important role in the development of colitis, and gut microbiota composition are different 
between patients with IBD and healthy individuals [8]. The incidence of colonic 
inflammation has also been associated with dietary patterns through the modification of 
gut microbiota [248]. The diet with high fat, high sugar, high protein and low fiber has 
been proposed to increase the risk of IBD. In contrast, dietary consumption of fruits and 
vegetables has been associated with lowered risk of IBD [10]. 
Accumulating evidence suggests that colonic inflammation may be prevented by 
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increased consumption of certain fruits and vegetables such as berries [10, 249]. Berries 
(e.g. chokeberry, red raspberry, strawberry, cowberry) and their extracts have been shown 
to have anti-inflammatory and anticancer effects in intestine in various animal models 
such as AOM-induced rat colon cancer model, Apc 1638+/- mouse and Muc2-/- mouse 
model, and DSS-induced colitis models [12-14]. Strawberry is one of the most popular 
berry fruits, which is abundant in polyphenols that have been associated with anti-
oxidation, anti-inflammation and anti-cancer bioactivities. Strawberry juice exhibited 
anti-inflammatory effects in LPS-treated macrophage by decreasing the production of 
pro-inflammatory cytokines [23], and inhibited the cell proliferation of human colon 
cancer cell lines [17]. A human study showed that consumption of strawberry could 
increase the serum antioxidant capacity [24]. The consumption of strawberry beverage 
was associated with the amelioration of postprandial inflammatory response [25]. These 
evidences suggested the promising bioactivity of berry fruits against the colonic 
inflammation. Whole strawberry contains vitamins, flavonoids, phenolic acids, 
anthocyanins, polysaccharides and fiber [17], which may exhibit stronger anti-
inflammatory effects when compared to the extracts. However, there is no detailed 
mechanistic information available on the potential protective effects of whole strawberry 
against IBD. Therefore, in this study, for the first time we determined anti-inflammatory 




5.2 Materials and methods 
5.2.1 Animals, diet and experiment design 
Male CD-1 mice were purchased from Charles River Laboratories (Wilmington, 
MA, USA). All animal use was in compliance with regulations of Institutional Animal 
Care and Use Committee of University of Massachusetts Amherst. The mice were 
randomly divided into six groups (n=10) after one-week acclimation. Three groups were 
treated with 1.5% (w/v) DSS in drinking water for 4 cycles (4 days/cycle, with 7-day 
recovery after each of the first three DSS cycles) to induce colitis. These three colitic 
groups were treated with AIN93G diet containing 0%, 2.5% or 5% (w/w) free-dried 
whole strawberry powder, respectively, throughout the entire experiment. The other three 
noncolitic groups were treated with regular drinking water plus AIN93G diet containing 
0%, 2.5% or 5% (w/w) WS, respectively, throughout the entire experiment.  
5.2.2 LC-MS analyses of polyphenols in whole strawberry powder 
Polyphenols in whole strawberry powder were extracted with 80% acetone with 
0.1% acetic acid for three times. Each time, the extraction mixture was sonicated for 30 
min at room temperature, and then the supernatant was collected by centrifuging at 3,500 
g for 5 min. The pooled supernatant was dried under vacuum and then re-dissolved in 
50% methanol aqueous before analysis by LC-MS. Identification and quantification of 
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polyphenols in strawberry were conducted using by LC-MS. Chromatographic separation 
of polyphenols was carried out on Kinetex XB-C18 column (100 mm ×4.6 mm, 2.6 μm, 
Phenomenex, Torrance, CA, USA). The mobile phase consisted of 0.1% formic acid in 
95% water mixed with 5% CAN (solvent A), and 0.1% formic acid in ACN (solvent B). 
The elution program was as follows: 0-2 min, isocratic elution with 5% B; 2-37 min, 5-
95% B; 37-40 min, 95-100% B; 40-46 min, 100-5% B; 46-52 min, isocratic elution with 
5% B. The flow rate was 0.4 mL/min, and injection volume was 10 µL. Pelargonidin 3-
glucoside, pelargonidin 3-rutinoside, proanthocyanidins B1, catechin, myricetin, 
kaempferol were used as external standards, and pinostilbene was used as an internal 
standard. All chemicals were from Sigma Aldrich. 
5.2.3 Disease activity index (DAI), histological and immunohistochemistry evaluation 
DAI was evaluated by the scores of bodies weight loss (the weight before each 
DSS treatment compared to that after the DSS treatment, scored as: 0, no change; 1, 1-5% 
loss; 2, 5-10% loss; 3, 10-20% loss), stool consistency (0, normal; 1, soft but firm; 2, soft; 
3, diarrhea), and fecal blood (0, none; 1-2, blood; 3, gross bleeding) [250]. Once the mice 
were sacrificed, colons were harvested and processed for histological analysis as we 
previously described [176, 251, 252]. The score system was as follows: epithelium: 0, 
normal; 1, loss of goblet cells; 2, loss of goblet cells in large areas; 3, loss of crypts; 4, 
loss of crypts in large areas. Infiltration: 0, none; 1, infiltrate around crypt basis; 2, 
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infiltrate reaching to mucosae; 3: extensive infiltration to mucosae; 4: infiltration of 
submucosa [253]. Immunohistochemistry analysis of the colon was performed as we 
previously described [251, 254, 255]. Processed tissue sections were treated with a 
primary antibody against inducible nitric oxide synthase (iNOS) and visualized after the 
treatment with a biotin-conjugated secondary antibody (Dako, Santa Clara, CA, USA). 
5.2.4 Western blot and enzyme-linked immunosorbent analysis (ELISA) 
Colonic mucosa was scrapped and lysed in RIPA buffer containing a protease 
inhibitor cocktail, and phosphotase inhibitor. Contents of protein were determined by 
BCA kit. Samples were subjected to SDS-PAGE, and proteins were transferred to 
nitrocellulose membranes. Membranes were then processed and visualized by Odyssey 
CLx system (LI-COR Biosciences, Lincoln, NE, USA).  
Colonic mucosa was scrapped and homogenized in MSD Tris Lysis buffer 
(Rockville, Maryland, USA) containing protease inhibitor cocktail and phosphotase 
inhibitor. The protein content was quantified by BCA kit, and then cytokines were 
quantified by V-PLEX ELISA kit (Meso Scale Discovery, Rockville, Maryland, USA) 
following the manufacture’s procedure. 
5.2.5 Quantification of immune cells in the colonic mucosa and GSH/GSSG in the liver 
Distal colons were lysed with Hanks’s balanced salt solution (1mM DTT and 5 
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mM EDTA) for 2 h at 4 ℃ after washing with cold PBS. Seventy μm sorters (BD 
Biosciences, San Jose, CS, USA) were used to obtain single-cell suspensions, followed 
by the staining with APC-conjugated CD11c antibody, FITC-conjugated CD45 antibody, 
PE/Cy7-conjugated Ly-6G/Ly-6C(Gr-1) antibody, PerCP/Cy5.5-conjugated F4/80 
antibody, and isotype control antibody (Biolegend, San Diego, CA, USA). BD 
LSRFortessa cell analyzer (BD Biosciences, San Jose, CA, USA) was used to quantify 
the stained cells, and data were analyzed by FlowJo software. 
Livers were rinsed in cold PBS before homogenization with PBS (1 mM EDTA), 
followed by centrifugation at 10,000 g for 15 min at 4 ℃. Supernatants were 
deproteinated with MPA reagent (Cayman Chemical, Ann Arbor, MI, USA). GSH and 
GSSG were quantified by a glutathione assay kit (Cayman Chemical, Ann Arbor, MI, 
USA). 
5.2.6 Quantification of SCFAs by gas chromatography 
SCFAs were extracted from cecal digesta with 0.05% phosphoric acid, followed 
by the vortex and centrifugation for 20 min at 14,000 rpm at 4 ℃. Supernatants were 
analyzed by gas chromatography with a flame ionization detector (Shimadzu GC-QP2010 
SE, Tokyo, Japan). Identification of SCFAs was achieved by comparing with the 
chemical standards (acetic acid, propionate acid, butyric acid, isovaleric acid, and valeric 
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acid (Sigma-Aldrich, St. Louis, MO, USA)), and 2-ethylbutyric acid was used as the 
internal reference. 
5.2.7 Microbial analysis 
Fecal pellets were store at -80 ℃ once being collected from mouse colon until 
analysis. Bacterial DNA was extracted from feces using PowerFecal DNA isolation kit 
(MoBio Laboratories, Inc., Carlsbad, CA, USA) following the manufacturer’s 
instructions. The concentration of DNA was measured by NanoDrop Spectrophotometer 
(ThermoScientific, Waltham, MA, USA). The primer sequences used to amplify V3-V4 
regions of 16S rRNA gene was:16S Amplicon PCR Forward Primer = 
5'TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG 
and 16S Amplicon PCR Reverse Primer = 
5’GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAA
TCC. The second PCR was conducted to attach dual indices and Illumina sequencing 
adapters using Nextera XT Index Kit (Illumina, San Diego, CA, USA). PCR products 
were quantified using Qubit dsDNA BR Assay kit (Life Technology, Carlsbad, CA, 
USA), and the size of PCR products was verified by DNA analysis ScreenTape Assay on 
Tape Station 2200 (Agilent Technologies, Santa Clara, CA, USA). PCR final products 
were pooled in equimolar concentration and diluted to 4nM and denatured by NaOH. 
After combining the amplicon library and PhiX control, the samples were loaded onto the 
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600-cycle MiSeq Reagent kit v3 cartridge and sequenced on an Illumina MiSeq platform 
(Illumina Inc, San Diego, CA, USA). 
 
Figure. 15 Dietary WS ameliorated symptoms of DSS-induced colitis in mice. (A) Body 
weight change of mice, and disease activity index (DAI) (n=10 per group); (B) Colon 
length and representative images of the mouse colon (n=8-10 per group); (C) Spleen 
weights (n=8-10 per group); (D) Representative images of H&E staining of the colon 
tissues (magnification: 300×) (n=6 per group); (E) Histological scores of colonic 
abnormality (n=6 per group); (F) The ratio of GSH/GSSG in the liver (n=8-10 per group); 
(G) Quantification of infiltrated immune cells in the distal colonic mucosa (n=6-8 per 
group). Data present mean ± SD, and * indicates p<0.05, ** indicates p<0.01. 
5.2.8 Data Analysis 
Microbial data were analyzed by Quantitative insights into microbial ecology 
88 
 
(QIIME) software pipeline v1.9.1. Comparison of two or more groups was analyzed by 
either one-way parametric ANOVA followed by Tukey’s post hoc test or one-way 
nonparametric ANOVA (Kruskal- Wallis test) followed by Dunn’s post hoc test.  
Table 5. Phenolic Compounds Identified by LC-MS in Whole Strawberry Powder (freeze-
dried). Data represented mean ± standard deviation (N = 3). 
5.3 Results and discussion 
5.3.1 Dietary whole strawberry inhibited colitic symptoms 
The doses of WS used in the experiment were 2.5% and 5% (w/w) in the mouse 
diet, which were equivalent to about 167 g (1.1 cup) and 334 g (2.2 cup) of fresh 
strawberry per day per person (60 kg), respectively. These doses are within the achievable 
range for humans. As shown in Figure 15A, during the experimental period, the body 
weight of the control mice kept increasing (at a decreasing rate) and reached plateau at 
the fourth DSS cycle. In contrast, DSS group (positive control) showed decreased body 
weight during the third DSS cycle and continued body weight loss during the third 
recovery period and the last DSS cycle. Dietary WS treatments slowed down the body 






pelargonidin 3-glucoside 9.22 433[M+H]
＋ 1398.02 ± 38.13 
pelargonidin 3-rutinoside 9.56 580[M+H]
＋ 568.49 ± 32.45 
proanthocyanidins B2 5.92 579[M+H]
＋ 97.28 ± 11.48 
catechin 8.29 291[M+H]
＋ 254.27 ± 18.30 
kaempferol 21.028 287[M+H]
＋ 17.47 ± 0.70 
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DSS group was much higher than that of the control group, and WS at both 2.5% and 
5.0% effectively decreased DAI (Fig. 15A). The shortening of the colon and increase of 
spleen weight are indicators of severity of colitis. Our results showed WS reversed the 
shortening of the colon and increase in spleen weight in colitic mice (Fig. 15B and C). 
These results demonstrated that dietary WS effectively inhibited the severity of colitis in 
DSS-treated mice. Strawberry is a rich source of bioactive components such as various 
polyphenols. Using LC-MS, we quantified the abundance of pelargonidin 3-glucoside, 
pelargonidin 3-rutinoside, proanthocyanidins B1, catechin, myricetin, and kaempferol in 
the whole strawberry powder. The results were shown in the Table 5. All of these 
components are potential contributors of the observed protective effects against colonic 
inflammation in mice. It is important to note that there might be synergistic interactions 
among different strawberry components, which might produce enhanced anti-
inflammatory effects. The exact mechanism of actions of each component and their 
interactions are important focuses of future investigations.   
5.3.2 Dietary whole strawberry ameliorated colonic injuries, reduced infiltration of 
immune cells, and improved cellular anti-oxidative status. 
Hematoxylin and Eosin (H&E) staining indicated that DSS treatment caused 
severe colonic injuries, evidenced by the epithelium distortion, large areas of depletion of 
goblet cells, damage of crypts and the infiltration of inflammatory cells, resulting in 
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much higher histopathological scores compared to the control group (Fig. 15D and E). In 
contrast, WS treatments (2.5% and 5%) significantly reduced the abnormal 
histopathological changes in the colon of the DSS-treated mice. The preserved colon 
architecture suggested the protective effect of dietary WS (2.5% and 5%) against DSS-
induced colonic injuries. 
In response to DSS treatment, infiltration of immune cells increased in the mouse 
colonic mucosa, which is similar to the situation of IBD patients [256]. Increased 
infiltration of neutrophils was reported in DSS treated mice, along with the high oxidative 
stress via production of ROS in the colon [257]. Our flow cytometry results indicated that 
DSS treatment significantly elevated the infiltration of total immune cells, macrophage, 
neutrophils and dendritic cells by 2.7-folds, 8.1-folds, 6.4-folds and 10.9-folds, 
respectively, in the mucosa of the distal colons when compared to the control group (Fig. 
15G). Dietary WS decreased the infiltration of these immune cells in the colon, 
especially, dietary WS almost reversed the infiltration of macrophage, neutrophils and 
dendritic cells. Similar to our results, polyphenol-rich apple extracts and red raspberries 
were shown to reduce the immune cell infiltration in a rat model of colitis [258]. 
Innate immunity is activated when special cells recognize pathogens, and this 
process triggers the production of ROS and cytokines that amplifies the host response 
[259]. Increased oxidative stress has been associated with extensive infiltration of 
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immune cells in DSS-induced colitis [260]. Antioxidants have been found effective in 
attenuating colitis. Glutathione is the most important intracellular ROS scavenger, and its 
depletion can be observed under inflammatory conditions [261]. We determined the ratio 
of GSH/GSSG in the liver, and the data showed that GSH/GSSG was markedly reduced 
in DSS-treated mice than the control mice, indicating the depletion of GSH and higher 
level of ROS in the DSS group than that in the control (Fig. 15F). Dietary WS (2.5% and 
5%) increased the GSH/GSSG ratio to the levels similar to that of the control mice, thus 
suggesting the protective effects of WS against ROS in colitic mice.5.3.3 Dietary whole 




Figure. 16 (A) Quantification of TNF-α, IL-1β, IFN-γ, IL-17, and IL-10 in the colonic 
mucosa (n=6-8 per group); (B) Western blot analysis of key signaling proteins in the 
colonic mucosa (Each lane contained protein of the colonic mucosa collected from the 
colon of 2-3 individual animals that were pooled for immunoblot analysis. A total number 
of 6-8 mice from each group were analyzed. Statistical significance in comparison with the 
control (*p < 0.05, ** p < 0.01, n = 3)); (C) Representative immunohistochemistry images 
of iNOS in the colonic tissues (magnification: 600×). Data present mean ± SD, and * 
represents p<0.05, ** represents p<0.01. 
Improper upregulation of proinflammatory cytokines is a marker of inflammation. 
IL-10 is considered an anti-inflammatory cytokine, the expression of IL-10 in colitic 
mice was higher than that in healthy mice (Fig. 16A), this may due to the self-defeating 
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response, indicating more severe colitis in DSS-treated mice. Also, as shown in Fig. 16A, 
DSS-treated mice showed drastically enhanced production of proinflammatory cytokines 
in the colonic mucosa than the control, such as TNF-α, IL-1β, IFN-γ and IL-17. Dietary 
WS effectively decreased the production of all five cytokines mentioned above in the 
DSS-treated mice. Considering the data on immune cells and cytokines, the trend of 
cytokine production in different groups was similar to that of the infiltration of the 
immune cells (Fig. 15G and Fig. 16A), which was consistent with the notion that 
infiltrated immune cells are the major producers of the various cytokines. These data 
suggest that anti-inflammatory effect of WS were at least partially due to maintenance of 
immune system homeostasis by reducing immune cell influx and overproduction of 
proinflammatory cytokines in the colon. 
5.3.3 Dietary whole strawberry modulated inflammation-related signaling proteins 
To investigate the mechanism by which dietary WS inhibits the production of 
inflammation mediators, the expression of COX-2 and iNOS were determined. We found 
that levels of COX-2 and iNOS were elevated in colitic mice, whereas WS successfully 
decreased their expressions (Fig. 16B and C). The NF-κB signaling pathway strongly 
influences the pathogenesis of colitis, and dictates the expression of proinflammatory 
proteins, such as COX-2 and iNOS, which markedly increased in the DSS-treated mice 
[262]. The results showed that NF-κB pathway was activated in the colon of the colitic 
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mice, evidenced by the elevated expression of p50, a vital subunit of NF-κB (Fig. 16B). 
Dietary WS effectively suppressed the activation of NF-κB signaling. Similar to these 
findings, polyphenol-rich fruits or extracts were found to suppress NF-κB signaling 
pathway in DSS-treated rodent models [11, 14]. AP-1 is another critical pathway that 
involved in the proinflammatory response. The DSS-induced colitis was associated with 
increased expression levels of c-JUN, the key component in AP-1 pathway [263]. The 
results showed the colonic level of c-JUN was increased by 5.6-fold in the colitic mice 
than the control. Whereas, dietary WS (2.5% and 5%) treatments decreased the 
expression of c-JUN by 73% and 91%, respectively in colitic mice.  
The p53, an important tumor suppressor, can be activated and its expression level 
has been found increased in colitis [264], the elevated p53 expression in colitic mice is 
likely to be adaptive tissue response to facilitate the damaged cells. We found that the 
expression of p53 was increased in the colitic mice, but it was decreased by dietary WS 
treatments, suggesting the less severe colitis with dietary WS treatment. The activity of 
cleaved caspase-3 (C-C 3) was found increased in both colon cancer cells treated with 
LPS and the colon of the DSS-treated mice [265, 266], which may be related with tissue 
injuries caused by the colonic inflammation. Consistent with these findings, Figure 16B 
showed that DSS treatment increased expression levels of cleaved caspase 3 by 4.8-folds 
compared to the control. Dietary WS (2.5% and 5%) suppressed the expression of 
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cleaved caspase 3 by 76% and 98% compared to the DSS group, indicating that WS 
protected the colonic tissues against DSS-induced tissue injuries.  
5.3.4 Dietary whole strawberry alleviated gut microbiota dysbiosis 
Accumulating evidence suggested that gut microbiota play a vital role in colonic 
inflammation, and the change from “disease-free” to “disease” microbiota composition is 
an important characteristic of IBD [267]. In the disease-free (noncolitic) mice, i.e. the 
control and WS (2.5% or 5%) groups, 16S rRNA sequencing showed that 5% WS 
treatment significantly increased α diversity of the microbiota, which was assessed by PD 
whole tree (Fig. 17A), and modulated β diversity of the microbiota, which was assessed 
by principal coordinate analysis of the weighted UniFrac Index(P<0.05, Fig. 17B), 
although 2.5% WS did not cause significant change of α or β diversity of the gut 




Figure. 17 The effects of WS on gut microbiota. (A) Effect of WS on α diversity of fecal 
bacteria in healthy mice, assessed by PD whole tree analysis; (B) Effect of WS on β 
diversity of fecal bacteria in healthy mice, assessed by principal coordinates analysis; (C) 
Effect of WS on α diversity of fecal bacteria in diseased mice, assessed by PD whole tree 
analysis; (D) Effect of WS on β diversity of fecal bacteria in diseased mice, assessed by 
principal coordinates analysis;(E) Relative abundance of bacteria taxa, different letters 
mean statistically differences (p<0.05). *p<0.05. Data are presented as mean ± SEM or 




Figure. 18 LEfSe analysis of microbiota. (A) Taxonomic cladogram obtained from LEfSe 
analysis of 16s sequences; (B) Only taxa meeting an LDA score threshold > 2 are shown. 
The α diversity was significantly decreased in colitic mice compared with 
noncolitic mice (Fig. 17C). 2.5% WS treatment did not significantly change α or β 
diversity in colitic mice. However, 5% WS treatment profoundly increased α diversity of 
colitic mice, which was assessed by PD whole tree (Fig. 17C). The β diversity was 
profoundly changed in 5% WS-treated colitic mice (Fig. 17D), as observed in the 
principal coordinates analysis of the weighted UniFrac Index. The three first principal 
coordinates explained 82.73% of the variation observed between all the groups. The 
change of gut microbiota between different groups was also evidenced by LEfSe analysis 
98 
 
(Figure 18), and Fig. 4B showed the most differentially abundant taxons of different 
groups. At the genus level, colitic mice showed 4.3-fold, 82.1-fold, 2.5-fold, and 2.8-fold 
higher abundance of Akkermansia, Dorea, Bilophila and Bacteroides and 224.1-fold and 
58.1-fold lower abundance of Bifidobacterium and Lactobacillus than the noncolitic 
control mice, respectively (Fig. 17E). The LEfSe analysis also validated aforementioned 
results (Fig. 18A and 4B). Linear discriminant analysis (LDA) showed the higher 
abundance of Akkermansia, Dorea, Bilphila and Bacteroides in colitic mice than those in 
non-colitic mice (Fig. 18B).In consistent with our results, Akkermansia shows positive 
correlation with IBD patients [268], which may due to the Akkermansia’s mucin-
degrading ability and its highly immunostimulatory lipopolysaccharide activity,38 which 
results in high production of pro-inflammatory cytokines. Mucin is the major component 
of colonic mucosa, and the increased amount of Akkermansia may contribute to the 
mucosa damage. And dietary WS decreased both pro-inflammatory cytokines and the 
abundance of Akkermansia (Fig. 16A,17E and 18). The enrichment of Bilophila, as an 
opportunistic pathogen, is reported in colitis mice [269], which is similar to our results. 
Commensal Bacteroides was reported to induce colitis in mice, which is supportive to 
their potential role in pro-inflammation in the colitic mice that hosted higher abundance 
of Bacteroides than the noncolitic mice in this study [270]. Bifidobacterium and 
Lactobacillus have shown protective effects against colonic inflammation. Low 
abundance of these two bacteria in colitic mice might contribute to the development of 
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colitis. Intriguingly, dietary WS (2.5%) treatment at least partially or even completely 
reversed the alterations of gut microbiota in colitic mice by decreasing the abundance of 
Akkermansia, Dorea, Bilophila and Bacteroides, and increasing the abundance of 
Bifidobacterium and Lactobacillus. These results demonstrated dietary WS alleviated 
microbiota dysbiosis in DSS-induced colitis. 
5.3.5 Dietary whole strawberry restored the production of SCFAs in the cecum 
It has been shown that IBD was usually associated with change of gut microbiota, 
and concurrent decrease of SCFAs [260]. SCFAs have been found to have anti-
inflammatory effects, and they were mainly produced by Bacteroidetes and Firmicutes 
phyla [271]. The data showed that the cecal levels of acetic acid, propionate acid, butyric 
acid, and valeric acid in the colitic mice 45.6%, 19.4%, 60.8% and 44.5% lower than that 
in the noncolitic control mice, respectively (Fig. 19A). Concomitantly, the abundance of 
Firmicutes was much lower in the colitic mice than the noncolitic control, which might 
contribute to the low levels of SCFAs.42 Dietary WS (2.5%) did not change the cecal 
levels of SCFAs in the noncolitic mice, but significantly increased the production of 
SCFAs in the colitic mice to the same levels found in the noncolitic control mice. Since 
WS did not increase the levels of SCFAs in noncolitic mice, it is likely that dietary WS 
increased SCFAs production in the colitic mice due to its effects in altering the 




Figure. 19 (A) Quantification of SCFAs in the cecum. (B) Heatmap of the correlation 
between bacteria and cytokines or SCFAs. Data are presented as mean ± SD (n=5), and * 
represents p<0.05, ** represents p<0.01. 
According to these results, colitic mice had improper upregulation of cytokines in 
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the colonic tissue, reduced production of SCFAs in the cecum, and increased abundance 
of pathogens and decreased abundance of beneficial bacterial species in the feces, when 
compared to the noncolitic control mice. Intriguingly, dietary WS effectively alleviated 
and/or reversed the aforementioned abnormality in the colitic mice. Since gut microbiota 
are responsible for the production of SCFAs in the colon, and can modulate the secretion 
of pro-inflammatory cytokines, especially when there is dysbiosis in the colon, to 
understand the role of gut microbiota in mediating the protective effects of dietary WS 
against colitis, the correlation between composition of gut microbiota and production of 
cytokines or SCFAs among the different experimental groups of mice was analyzed (Fig. 
19B). The results showed that Akkermansia and Dorea presented a negative correlation 
with the production of SCFAs, especially for the butyrate that is an important anti-
inflammatory component in the colon. Moreover, Akkermansia and Dorea also showed a 
strong positive correlation with TNF-α, a proinflammatory cytokine. Considering the 
relatively higher abundance of Akkermansia and Dorea in colitic mice than that in the 
non-colitic control mice (Fig 17E), Akkermansia and Dorea may exert proinflammatory 
effects in DSS-induced colitis. Consistent with our findings, the increase of Akkermansia 
and Dorea was previously reported in the DSS-induced colitis [272, 273]. The abundance 
of Bifidobacterium and Lactobacillus was negatively correlated with the production of 
TNF-α, and positively correlated with the production of butyrate, indicating a potential 
protective effect of these bacteria against colonic inflammation [274]. 
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For the first time, these results demonstrated the protective effect of dietary WS 
against the development of colonic inflammation in the DSS-treated mice. This protective 
effect was closely associated with restoration of immune homeostasis by dietary WS, 
which was evidenced by that dietary WS reduced immune cell infiltration and lowered 
levels of proinflammatory cytokines in the colonic mucosa of colitic mice. The anti-
inflammatory effects of dietary WS were also closely related with its ability to alleviate 
the dysbiosis of gut microbiota in the colitic mice, which was evidenced by the increased 
abundance of beneficial bacteria, the decreased abundance of harmful bacteria, and the 
increased production of SCFAs caused by dietary WS in the colon of the colitic mice. 
Overall, our findings provided a solid scientific basis for utilization of strawberry for the 






Intake of whole foods, such as fruits and vegetables, profoundly modulates the 
composition and function of gut microbiota. These alterations of gut microbiota may (i) 
produce a better health status in disease-free population to lower the risks of various 
diseases, and (ii) alleviate the disease severity in patients with microbiota-associated 
diseases such as obesity and colonic inflammation. MACs and polyphenols are two major 
types of components responsible for the modulating effects of fruits and vegetables on 
gut microbiota. They have a reciprocal interaction with gut microbiota, in which MACs 
and polyphenols alter the structure of microbiota and microbiota transforms MACs and 
polyphenols to bioactive metabolites, such as SCFAs and phenolic acids, respectively. 
These microbiota-derived metabolites could promote host health by targeting both host 
tissues and gut microbiota. Furthermore, coexistence of whole food components, their 
metabolites and microbiota in the large intestine provides opportunities for them to 
interact with each other and produce certain biological functions that are otherwise 
impossible. The relationship among whole foods, gut microbiota, and the host is 
complex, which makes it challenging to study. Nevertheless, a highly interdisciplinary 
and dynamic approach giving special considerations of the physiological relevance of the 
experimental conditions is needed to elucidate the role of whole foods in modulating gut 
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microbiota and associated diseases. 
This study provided an understanding of EP and NEP from cranberry and 
strawberry in terms of their chemical properties and biological functions. Chemical 
profile of cranberry and strawberry NEP was firstly determined, which showed that NEP 
possessed higher contents of phenolic acids than EP. EP fraction in fruits have been 
extensively studied, such as their anti-oxidant, anti-inflammatory, anti-cancer, and 
antibacterial effects. However, reports about NEP have been scarce. NEP could bind to 
fiber and they may reach colon intact [15], so that the biological effects of NEP have 
been considered important for colon health. Our results indicated that both EP and NEP 
from cranberry had various biological effects. Importantly, NEP showed the promising 
anti-inflammatory and anti-cancer capacities. The high bioavailability of NEP in the 
colon facilitate the realization of these activities in the colonic tissues. Moreover, the 
potential interaction between gut microbiota and NEP could also play an important role in 
colon health. NEP could be biotransformed by gut microbiota to produce bioactive 
metabolites that may contribute to the promotion of colon health as well [197].  
Therefore, it is important to investigate the interaction of gut microbiota and NEP in the 
colon in terms of production of bioactive metabolites. Meanwhile, composition and 
functions of gut microbiota can be altered by the presence of polyphenols in the colon, 
which in turn could affect colon health [198]. Unfortunately, the mode of interplay 
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between NEP and gut microbiota in the colon is largely unknown, and much more efforts 
are needed to explore this promising research area. The knowledge obtained from our 
study is helpful for a better understanding of polyphenols in berries, especially the 
potential biological effects of NEP in the colon. Overall, this study provided the first line 
of evidence to support the notion that NEP could be a promising beneficial agent for 
colon health. Certainly, further investigation is warranted to elucidate the detailed model 
of actions of NEP in the colon, especially in relationship with gut microbiota.  
Furthermore, this study demonstrated the protective effect of dietary WS against 
the development of colonic inflammation in the DSS-treated mice. This protective effect 
was closely associated with restoration of immune homeostasis by dietary WS, which 
was evidenced by that dietary WS reduced immune cell infiltration and lowered levels of 
proinflammatory cytokines in the colonic mucosa of colitic mice. The anti-inflammatory 
effects of dietary WS were also closely related with its ability to alleviate the dysbiosis of 
gut microbiota in the colitic mice, which was evidenced by the increased abundance of 
beneficial bacteria, the decreased abundance of harmful bacteria, and the increased 
production of SCFAs caused by dietary WS in the colon of the colitic mice. Overall, our 
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